cancer_group,confounder,hugo_symbol,cancer,variable,y,n,mean,median,q1,q2,ras,codon_range,codon_label
single,Sex,KRAS,appendiceal cancer,Female,0,174,0.002,0.001,0,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,appendiceal cancer,Male,1,167,0.005,0.003,0,0.018,KRAS_12A,12A,NA
single,Sex,KRAS,colorectal cancer,Female,71,3028,0.023,0.022,0.018,0.028,KRAS_12A,12A,NA
single,Sex,KRAS,colorectal cancer,Male,74,3696,0.021,0.021,0.017,0.025,KRAS_12A,12A,NA
single,Sex,KRAS,cancer of unknown primary,Female,8,1000,0.008,0.007,0.004,0.013,KRAS_12A,12A,NA
single,Sex,KRAS,cancer of unknown primary,Male,6,989,0.007,0.007,0.003,0.012,KRAS_12A,12A,NA
single,Sex,KRAS,non-small cell lung cancer,Female,147,5722,0.025,0.025,0.021,0.029,KRAS_12A,12A,NA
single,Sex,KRAS,non-small cell lung cancer,Male,79,4406,0.019,0.019,0.015,0.023,KRAS_12A,12A,NA
single,Sex,KRAS,breast cancer,Female,6,9284,0.001,0.001,0,0.001,KRAS_12A,12A,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.001,0.001,0,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,pancreatic cancer,Female,7,1153,0.006,0.005,0.003,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,pancreatic cancer,Male,6,1341,0.005,0.005,0.002,0.009,KRAS_12A,12A,NA
single,Sex,KRAS,leukemia,Female,2,637,0.003,0.003,0.001,0.008,KRAS_12A,12A,NA
single,Sex,KRAS,leukemia,Male,3,930,0.003,0.003,0.001,0.007,KRAS_12A,12A,NA
single,Sex,KRAS,melanoma,Female,1,1104,0.001,0,0,0.003,KRAS_12A,12A,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0.001,KRAS_12A,12A,NA
single,Sex,KRAS,head and neck cancer,Female,1,564,0.001,0.001,0,0.006,KRAS_12A,12A,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0.002,KRAS_12A,12A,NA
single,Sex,KRAS,uterine cancer,Female,31,2254,0.014,0.014,0.009,0.019,KRAS_12A,12A,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_12A,12A,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_12A,12A,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0,0,0.003,KRAS_12A,12A,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.001,0.001,0,0.005,KRAS_12A,12A,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.002,KRAS_12A,12A,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.002,KRAS_12A,12A,NA
single,Sex,KRAS,ovarian cancer,Female,14,2336,0.006,0.006,0.003,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,esophagogastric cancer,Female,2,504,0.004,0.003,0.001,0.009,KRAS_12A,12A,NA
single,Sex,KRAS,esophagogastric cancer,Male,4,1297,0.003,0.003,0.001,0.007,KRAS_12A,12A,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,KRAS_12A,12A,NA
single,Sex,KRAS,hepatobiliary cancer,Female,1,636,0.003,0.003,0,0.009,KRAS_12A,12A,NA
single,Sex,KRAS,hepatobiliary cancer,Male,6,739,0.007,0.006,0.003,0.014,KRAS_12A,12A,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,KRAS_12A,12A,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12A,12A,NA
single,Sex,KRAS,cns cancer,Female,4,1994,0.002,0.001,0.001,0.004,KRAS_12A,12A,NA
single,Sex,KRAS,cns cancer,Male,2,2569,0.001,0.001,0,0.003,KRAS_12A,12A,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,anal cancer,Female,0,102,0.005,0.002,0,0.023,KRAS_12A,12A,NA
single,Sex,KRAS,anal cancer,Male,1,47,0.015,0.009,0.001,0.061,KRAS_12A,12A,NA
single,Sex,KRAS,neuroendocrine tumors,Female,1,166,0.005,0.003,0,0.018,KRAS_12A,12A,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0.002,0.001,0,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,bladder cancer,Female,1,393,0.002,0.002,0,0.007,KRAS_12A,12A,NA
single,Sex,KRAS,bladder cancer,Male,2,1188,0.002,0.002,0,0.005,KRAS_12A,12A,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.007,0.005,0,0.029,KRAS_12A,12A,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0.003,0.001,0,0.015,KRAS_12A,12A,NA
single,Sex,KRAS,small bowel cancer,Female,1,78,0.018,0.016,0.003,0.045,KRAS_12A,12A,NA
single,Sex,KRAS,small bowel cancer,Male,3,132,0.021,0.019,0.006,0.047,KRAS_12A,12A,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,KRAS_12A,12A,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.01,KRAS_12A,12A,NA
single,Sex,KRAS,bone cancer,Female,2,242,0.007,0.005,0.001,0.02,KRAS_12A,12A,NA
single,Sex,KRAS,bone cancer,Male,0,328,0.002,0.001,0,0.008,KRAS_12A,12A,NA
single,Sex,KRAS,vaginal cancer,Female,1,78,0.015,0.011,0.001,0.05,KRAS_12A,12A,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_12A,12A,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.003,KRAS_12A,12A,NA
single,Sex,KRAS,ampullary cancer,Female,1,41,0.019,0.012,0.001,0.073,KRAS_12A,12A,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0.007,0.003,0,0.033,KRAS_12A,12A,NA
single,Sex,KRAS,small cell lung cancer,Female,1,193,0.004,0.003,0,0.015,KRAS_12A,12A,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0.002,0.001,0,0.009,KRAS_12A,12A,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_12A,12A,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.004,0.003,0,0.014,KRAS_12A,12A,NA
single,Sex,KRAS,germ cell tumor,Male,7,711,0.009,0.009,0.004,0.017,KRAS_12A,12A,NA
single,Sex,KRAS,nerve sheath tumor,Female,1,80,0.01,0.007,0,0.036,KRAS_12A,12A,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0.006,0.003,0,0.025,KRAS_12A,12A,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.003,0,0,0.029,KRAS_12A,12A,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.041,KRAS_12A,12A,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.005,0,0,0.057,KRAS_12A,12A,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.003,0.002,0,0.008,KRAS_12A,12A,NA
single,Sex,KRAS,b cell lymphoma,Male,1,567,0.002,0.002,0,0.007,KRAS_12A,12A,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.001,0,0,0.016,KRAS_12A,12A,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.001,0,0,0.016,KRAS_12A,12A,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.025,KRAS_12A,12A,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,KRAS_12A,12A,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.008,KRAS_12A,12A,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.008,KRAS_12A,12A,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.016,KRAS_12A,12A,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.014,KRAS_12A,12A,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.001,0,0,0.015,KRAS_12A,12A,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.055,KRAS_12A,12A,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.038,KRAS_12A,12A,NA
single,Sex,KRAS,appendiceal cancer,Female,6,174,0.03,0.028,0.013,0.057,KRAS_12C,12C,NA
single,Sex,KRAS,appendiceal cancer,Male,3,167,0.024,0.023,0.007,0.046,KRAS_12C,12C,NA
single,Sex,KRAS,colorectal cancer,Female,110,3028,0.035,0.035,0.029,0.042,KRAS_12C,12C,NA
single,Sex,KRAS,colorectal cancer,Male,102,3696,0.029,0.029,0.023,0.034,KRAS_12C,12C,NA
single,Sex,KRAS,cancer of unknown primary,Female,39,1000,0.036,0.036,0.026,0.049,KRAS_12C,12C,NA
single,Sex,KRAS,cancer of unknown primary,Male,22,989,0.025,0.025,0.016,0.036,KRAS_12C,12C,NA
single,Sex,KRAS,non-small cell lung cancer,Female,755,5722,0.131,0.131,0.123,0.14,KRAS_12C,12C,NA
single,Sex,KRAS,non-small cell lung cancer,Male,458,4406,0.105,0.105,0.096,0.114,KRAS_12C,12C,NA
single,Sex,KRAS,breast cancer,Female,8,9284,0.001,0.001,0,0.002,KRAS_12C,12C,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.002,0.001,0,0.013,KRAS_12C,12C,NA
single,Sex,KRAS,soft tissue sarcoma,Female,4,1413,0.002,0.002,0.001,0.005,KRAS_12C,12C,NA
single,Sex,KRAS,soft tissue sarcoma,Male,1,1360,0.001,0.001,0,0.004,KRAS_12C,12C,NA
single,Sex,KRAS,pancreatic cancer,Female,8,1153,0.008,0.008,0.004,0.013,KRAS_12C,12C,NA
single,Sex,KRAS,pancreatic cancer,Male,14,1341,0.01,0.009,0.006,0.015,KRAS_12C,12C,NA
single,Sex,KRAS,leukemia,Female,0,637,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,melanoma,Male,1,1742,0.001,0.001,0,0.002,KRAS_12C,12C,NA
single,Sex,KRAS,head and neck cancer,Female,1,564,0.002,0.001,0,0.005,KRAS_12C,12C,NA
single,Sex,KRAS,head and neck cancer,Male,1,1179,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,uterine cancer,Female,26,2254,0.012,0.012,0.008,0.016,KRAS_12C,12C,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,ovarian cancer,Female,10,2336,0.004,0.004,0.002,0.007,KRAS_12C,12C,NA
single,Sex,KRAS,esophagogastric cancer,Female,2,504,0.003,0.003,0.001,0.008,KRAS_12C,12C,NA
single,Sex,KRAS,esophagogastric cancer,Male,3,1297,0.003,0.003,0.001,0.006,KRAS_12C,12C,NA
single,Sex,KRAS,thyroid cancer,Female,1,537,0.002,0.002,0,0.006,KRAS_12C,12C,NA
single,Sex,KRAS,thyroid cancer,Male,1,480,0.002,0.002,0,0.007,KRAS_12C,12C,NA
single,Sex,KRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,KRAS_12C,12C,NA
single,Sex,KRAS,hepatobiliary cancer,Female,4,636,0.007,0.007,0.003,0.013,KRAS_12C,12C,NA
single,Sex,KRAS,hepatobiliary cancer,Male,6,739,0.008,0.007,0.003,0.014,KRAS_12C,12C,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0.001,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,kidney cancer,Male,1,1002,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12C,12C,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.005,KRAS_12C,12C,NA
single,Sex,KRAS,neuroendocrine tumors,Female,1,166,0.006,0.005,0.001,0.019,KRAS_12C,12C,NA
single,Sex,KRAS,neuroendocrine tumors,Male,1,193,0.006,0.005,0.001,0.018,KRAS_12C,12C,NA
single,Sex,KRAS,bladder cancer,Female,1,393,0.004,0.004,0.001,0.01,KRAS_12C,12C,NA
single,Sex,KRAS,bladder cancer,Male,7,1188,0.005,0.005,0.002,0.01,KRAS_12C,12C,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,KRAS_12C,12C,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,KRAS_12C,12C,NA
single,Sex,KRAS,small bowel cancer,Female,2,78,0.035,0.034,0.009,0.071,KRAS_12C,12C,NA
single,Sex,KRAS,small bowel cancer,Male,6,132,0.041,0.039,0.017,0.076,KRAS_12C,12C,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,KRAS_12C,12C,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.011,KRAS_12C,12C,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,vaginal cancer,Female,1,78,0.015,0.011,0.001,0.051,KRAS_12C,12C,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.002,KRAS_12C,12C,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.002,KRAS_12C,12C,NA
single,Sex,KRAS,ampullary cancer,Female,1,41,0.036,0.032,0.005,0.087,KRAS_12C,12C,NA
single,Sex,KRAS,ampullary cancer,Male,3,65,0.041,0.038,0.011,0.094,KRAS_12C,12C,NA
single,Sex,KRAS,small cell lung cancer,Female,2,193,0.009,0.008,0.002,0.023,KRAS_12C,12C,NA
single,Sex,KRAS,small cell lung cancer,Male,1,205,0.007,0.006,0.001,0.019,KRAS_12C,12C,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_12C,12C,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_12C,12C,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.003,0.002,0,0.011,KRAS_12C,12C,NA
single,Sex,KRAS,germ cell tumor,Male,4,711,0.005,0.005,0.001,0.012,KRAS_12C,12C,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_12C,12C,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.022,KRAS_12C,12C,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.019,KRAS_12C,12C,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,KRAS_12C,12C,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0,0,0,0,KRAS_12C,12C,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.029,KRAS_12C,12C,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,KRAS_12C,12C,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.021,KRAS_12C,12C,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.016,KRAS_12C,12C,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.015,KRAS_12C,12C,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,KRAS_12C,12C,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.012,KRAS_12C,12C,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.011,KRAS_12C,12C,NA
single,Sex,KRAS,lung cancer,Male,1,16,0.07,0.053,0.003,0.23,KRAS_12C,12C,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.05,KRAS_12C,12C,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.032,KRAS_12C,12C,NA
single,Sex,KRAS,appendiceal cancer,Female,45,174,0.265,0.265,0.21,0.323,KRAS_12D,12D,NA
single,Sex,KRAS,appendiceal cancer,Male,47,167,0.275,0.274,0.221,0.337,KRAS_12D,12D,NA
single,Sex,KRAS,colorectal cancer,Female,417,3028,0.136,0.136,0.125,0.148,KRAS_12D,12D,NA
single,Sex,KRAS,colorectal cancer,Male,468,3696,0.128,0.128,0.118,0.138,KRAS_12D,12D,NA
single,Sex,KRAS,cancer of unknown primary,Female,58,1000,0.056,0.056,0.044,0.07,KRAS_12D,12D,NA
single,Sex,KRAS,cancer of unknown primary,Male,49,989,0.052,0.052,0.04,0.064,KRAS_12D,12D,NA
single,Sex,KRAS,non-small cell lung cancer,Female,263,5722,0.045,0.045,0.04,0.051,KRAS_12D,12D,NA
single,Sex,KRAS,non-small cell lung cancer,Male,169,4406,0.039,0.039,0.034,0.045,KRAS_12D,12D,NA
single,Sex,KRAS,breast cancer,Female,11,9284,0.001,0.001,0.001,0.002,KRAS_12D,12D,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.002,0.001,0,0.012,KRAS_12D,12D,NA
single,Sex,KRAS,soft tissue sarcoma,Female,7,1413,0.004,0.004,0.002,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,soft tissue sarcoma,Male,4,1360,0.004,0.004,0.001,0.007,KRAS_12D,12D,NA
single,Sex,KRAS,pancreatic cancer,Female,374,1153,0.321,0.321,0.297,0.348,KRAS_12D,12D,NA
single,Sex,KRAS,pancreatic cancer,Male,408,1341,0.307,0.307,0.283,0.33,KRAS_12D,12D,NA
single,Sex,KRAS,leukemia,Female,8,637,0.013,0.013,0.007,0.021,KRAS_12D,12D,NA
single,Sex,KRAS,leukemia,Male,13,930,0.014,0.013,0.008,0.021,KRAS_12D,12D,NA
single,Sex,KRAS,melanoma,Female,6,1104,0.005,0.005,0.002,0.009,KRAS_12D,12D,NA
single,Sex,KRAS,melanoma,Male,8,1742,0.005,0.005,0.002,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,head and neck cancer,Female,1,564,0.002,0.002,0,0.006,KRAS_12D,12D,NA
single,Sex,KRAS,head and neck cancer,Male,3,1179,0.003,0.002,0.001,0.006,KRAS_12D,12D,NA
single,Sex,KRAS,uterine cancer,Female,102,2254,0.045,0.045,0.037,0.054,KRAS_12D,12D,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,KRAS_12D,12D,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,3,483,0.005,0.004,0.001,0.012,KRAS_12D,12D,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.003,0.002,0,0.007,KRAS_12D,12D,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_12D,12D,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,KRAS_12D,12D,NA
single,Sex,KRAS,ovarian cancer,Female,82,2336,0.035,0.035,0.028,0.043,KRAS_12D,12D,NA
single,Sex,KRAS,esophagogastric cancer,Female,13,504,0.022,0.021,0.013,0.037,KRAS_12D,12D,NA
single,Sex,KRAS,esophagogastric cancer,Male,20,1297,0.017,0.017,0.011,0.024,KRAS_12D,12D,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0.001,0,0,0.005,KRAS_12D,12D,NA
single,Sex,KRAS,thyroid cancer,Male,3,480,0.005,0.005,0.001,0.014,KRAS_12D,12D,NA
single,Sex,KRAS,cervical cancer,Female,10,365,0.028,0.027,0.014,0.047,KRAS_12D,12D,NA
single,Sex,KRAS,hepatobiliary cancer,Female,28,636,0.042,0.041,0.03,0.057,KRAS_12D,12D,NA
single,Sex,KRAS,hepatobiliary cancer,Male,27,739,0.039,0.038,0.027,0.051,KRAS_12D,12D,NA
single,Sex,KRAS,kidney cancer,Female,1,420,0.003,0.003,0,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,kidney cancer,Male,4,1002,0.004,0.004,0.001,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_12D,12D,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12D,12D,NA
single,Sex,KRAS,cns cancer,Female,4,1994,0.002,0.002,0.001,0.004,KRAS_12D,12D,NA
single,Sex,KRAS,cns cancer,Male,4,2569,0.002,0.002,0.001,0.003,KRAS_12D,12D,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_12D,12D,NA
single,Sex,KRAS,anal cancer,Female,0,102,0.005,0.002,0,0.023,KRAS_12D,12D,NA
single,Sex,KRAS,anal cancer,Male,1,47,0.015,0.01,0.001,0.062,KRAS_12D,12D,NA
single,Sex,KRAS,neuroendocrine tumors,Female,5,166,0.036,0.035,0.015,0.063,KRAS_12D,12D,NA
single,Sex,KRAS,neuroendocrine tumors,Male,9,193,0.042,0.041,0.022,0.071,KRAS_12D,12D,NA
single,Sex,KRAS,bladder cancer,Female,9,393,0.021,0.021,0.012,0.035,KRAS_12D,12D,NA
single,Sex,KRAS,bladder cancer,Male,23,1188,0.02,0.02,0.013,0.028,KRAS_12D,12D,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,6,106,0.046,0.042,0.017,0.094,KRAS_12D,12D,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,2,142,0.023,0.022,0.004,0.051,KRAS_12D,12D,NA
single,Sex,KRAS,small bowel cancer,Female,8,78,0.114,0.113,0.061,0.174,KRAS_12D,12D,NA
single,Sex,KRAS,small bowel cancer,Male,17,132,0.123,0.121,0.079,0.179,KRAS_12D,12D,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.002,KRAS_12D,12D,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.004,KRAS_12D,12D,NA
single,Sex,KRAS,bone cancer,Female,1,242,0.004,0.003,0,0.012,KRAS_12D,12D,NA
single,Sex,KRAS,bone cancer,Male,1,328,0.004,0.003,0,0.011,KRAS_12D,12D,NA
single,Sex,KRAS,vaginal cancer,Female,1,78,0.015,0.011,0.001,0.051,KRAS_12D,12D,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.005,KRAS_12D,12D,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.004,KRAS_12D,12D,NA
single,Sex,KRAS,ampullary cancer,Female,12,41,0.274,0.27,0.179,0.396,KRAS_12D,12D,NA
single,Sex,KRAS,ampullary cancer,Male,16,65,0.258,0.256,0.172,0.353,KRAS_12D,12D,NA
single,Sex,KRAS,small cell lung cancer,Female,1,193,0.009,0.008,0.001,0.023,KRAS_12D,12D,NA
single,Sex,KRAS,small cell lung cancer,Male,3,205,0.012,0.011,0.003,0.028,KRAS_12D,12D,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_12D,12D,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_12D,12D,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.004,0.002,0,0.016,KRAS_12D,12D,NA
single,Sex,KRAS,germ cell tumor,Male,9,711,0.012,0.011,0.005,0.021,KRAS_12D,12D,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_12D,12D,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_12D,12D,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.003,0,0,0.029,KRAS_12D,12D,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.001,0,0,0.013,KRAS_12D,12D,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.002,0,0,0.026,KRAS_12D,12D,NA
single,Sex,KRAS,b cell lymphoma,Female,2,395,0.004,0.003,0.001,0.011,KRAS_12D,12D,NA
single,Sex,KRAS,b cell lymphoma,Male,1,567,0.003,0.003,0,0.008,KRAS_12D,12D,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.035,KRAS_12D,12D,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.034,KRAS_12D,12D,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.024,KRAS_12D,12D,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,KRAS_12D,12D,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,KRAS_12D,12D,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,KRAS_12D,12D,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.023,KRAS_12D,12D,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,KRAS_12D,12D,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.005,0,0,0.058,KRAS_12D,12D,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,1,11,0.101,0.077,0.004,0.323,KRAS_12D,12D,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.03,KRAS_12D,12D,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,colorectal cancer,Female,1,3028,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,colorectal cancer,Male,0,3696,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,cancer of unknown primary,Female,2,1000,0.002,0.002,0,0.005,KRAS_12F,12F,NA
single,Sex,KRAS,cancer of unknown primary,Male,1,989,0.002,0.001,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,non-small cell lung cancer,Female,18,5722,0.003,0.003,0.002,0.005,KRAS_12F,12F,NA
single,Sex,KRAS,non-small cell lung cancer,Male,14,4406,0.003,0.003,0.002,0.005,KRAS_12F,12F,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,pancreatic cancer,Female,1,1153,0.001,0,0,0.003,KRAS_12F,12F,NA
single,Sex,KRAS,pancreatic cancer,Male,0,1341,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,leukemia,Female,0,637,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,uterine cancer,Female,0,2254,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,KRAS_12F,12F,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,KRAS_12F,12F,NA
single,Sex,KRAS,ovarian cancer,Female,1,2336,0,0,0,0.002,KRAS_12F,12F,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,KRAS_12F,12F,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12F,12F,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.003,KRAS_12F,12F,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.003,KRAS_12F,12F,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.002,KRAS_12F,12F,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_12F,12F,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,KRAS_12F,12F,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.008,KRAS_12F,12F,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.003,KRAS_12F,12F,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0,0,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0,0,0,0.003,KRAS_12F,12F,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_12F,12F,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,KRAS_12F,12F,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.001,0,0,0.014,KRAS_12F,12F,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,KRAS_12F,12F,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,KRAS_12F,12F,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0,0,0,0,KRAS_12F,12F,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,KRAS_12F,12F,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,KRAS_12F,12F,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,KRAS_12F,12F,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,KRAS_12F,12F,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,KRAS_12F,12F,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,KRAS_12F,12F,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,KRAS_12F,12F,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,KRAS_12F,12F,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.037,KRAS_12F,12F,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,KRAS_12F,12F,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,KRAS_12F,12F,NA
single,Sex,KRAS,appendiceal cancer,Female,2,174,0.01,0.009,0.002,0.026,KRAS_12R,12R,NA
single,Sex,KRAS,appendiceal cancer,Male,1,167,0.009,0.008,0.001,0.023,KRAS_12R,12R,NA
single,Sex,KRAS,colorectal cancer,Female,19,3028,0.006,0.006,0.004,0.009,KRAS_12R,12R,NA
single,Sex,KRAS,colorectal cancer,Male,15,3696,0.005,0.005,0.003,0.007,KRAS_12R,12R,NA
single,Sex,KRAS,cancer of unknown primary,Female,7,1000,0.008,0.008,0.004,0.013,KRAS_12R,12R,NA
single,Sex,KRAS,cancer of unknown primary,Male,10,989,0.009,0.009,0.005,0.015,KRAS_12R,12R,NA
single,Sex,KRAS,non-small cell lung cancer,Female,24,5722,0.004,0.004,0.003,0.006,KRAS_12R,12R,NA
single,Sex,KRAS,non-small cell lung cancer,Male,12,4406,0.003,0.003,0.002,0.005,KRAS_12R,12R,NA
single,Sex,KRAS,breast cancer,Female,4,9284,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.001,0,0,0.009,KRAS_12R,12R,NA
single,Sex,KRAS,soft tissue sarcoma,Female,2,1413,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,soft tissue sarcoma,Male,1,1360,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,pancreatic cancer,Female,131,1153,0.112,0.112,0.097,0.13,KRAS_12R,12R,NA
single,Sex,KRAS,pancreatic cancer,Male,145,1341,0.109,0.109,0.095,0.125,KRAS_12R,12R,NA
single,Sex,KRAS,leukemia,Female,0,637,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,leukemia,Male,2,930,0.002,0.002,0,0.005,KRAS_12R,12R,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0.002,KRAS_12R,12R,NA
single,Sex,KRAS,melanoma,Male,3,1742,0.002,0.001,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_12R,12R,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_12R,12R,NA
single,Sex,KRAS,uterine cancer,Female,2,2254,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,2,724,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,KRAS_12R,12R,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,KRAS_12R,12R,NA
single,Sex,KRAS,ovarian cancer,Female,10,2336,0.004,0.004,0.002,0.007,KRAS_12R,12R,NA
single,Sex,KRAS,esophagogastric cancer,Female,2,504,0.003,0.003,0,0.01,KRAS_12R,12R,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0.002,KRAS_12R,12R,NA
single,Sex,KRAS,thyroid cancer,Female,1,537,0.002,0.001,0,0.006,KRAS_12R,12R,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0.001,0,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,KRAS_12R,12R,NA
single,Sex,KRAS,hepatobiliary cancer,Female,2,636,0.003,0.002,0,0.007,KRAS_12R,12R,NA
single,Sex,KRAS,hepatobiliary cancer,Male,1,739,0.002,0.002,0,0.006,KRAS_12R,12R,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_12R,12R,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_12R,12R,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,KRAS_12R,12R,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12R,12R,NA
single,Sex,KRAS,cns cancer,Female,1,1994,0.001,0,0,0.002,KRAS_12R,12R,NA
single,Sex,KRAS,cns cancer,Male,1,2569,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,prostate cancer,Male,3,2436,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,neuroendocrine tumors,Female,1,166,0.006,0.005,0.001,0.019,KRAS_12R,12R,NA
single,Sex,KRAS,neuroendocrine tumors,Male,1,193,0.006,0.005,0.001,0.018,KRAS_12R,12R,NA
single,Sex,KRAS,bladder cancer,Female,1,393,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Sex,KRAS,bladder cancer,Male,2,1188,0.002,0.002,0,0.005,KRAS_12R,12R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0.008,0.005,0,0.031,KRAS_12R,12R,NA
single,Sex,KRAS,small bowel cancer,Male,3,132,0.02,0.017,0.004,0.05,KRAS_12R,12R,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,KRAS_12R,12R,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.008,KRAS_12R,12R,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.003,KRAS_12R,12R,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,ampullary cancer,Female,1,41,0.03,0.026,0.004,0.079,KRAS_12R,12R,NA
single,Sex,KRAS,ampullary cancer,Male,2,65,0.031,0.027,0.006,0.076,KRAS_12R,12R,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_12R,12R,NA
single,Sex,KRAS,germ cell tumor,Female,1,175,0.009,0.008,0.001,0.019,KRAS_12R,12R,NA
single,Sex,KRAS,germ cell tumor,Male,7,711,0.009,0.009,0.004,0.017,KRAS_12R,12R,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,KRAS_12R,12R,NA
single,Sex,KRAS,penile cancer,Male,1,25,0.045,0.034,0.002,0.149,KRAS_12R,12R,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,KRAS_12R,12R,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,KRAS_12R,12R,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.003,0.002,0,0.008,KRAS_12R,12R,NA
single,Sex,KRAS,b cell lymphoma,Male,1,567,0.002,0.002,0,0.006,KRAS_12R,12R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,KRAS_12R,12R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,KRAS_12R,12R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,KRAS_12R,12R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,KRAS_12R,12R,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,KRAS_12R,12R,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,KRAS_12R,12R,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,KRAS_12R,12R,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,KRAS_12R,12R,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.037,KRAS_12R,12R,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,KRAS_12R,12R,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,KRAS_12R,12R,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0.002,0.001,0,0.011,KRAS_12S,12S,NA
single,Sex,KRAS,appendiceal cancer,Male,1,167,0.005,0.003,0,0.018,KRAS_12S,12S,NA
single,Sex,KRAS,colorectal cancer,Female,66,3028,0.021,0.021,0.016,0.026,KRAS_12S,12S,NA
single,Sex,KRAS,colorectal cancer,Male,60,3696,0.017,0.017,0.013,0.021,KRAS_12S,12S,NA
single,Sex,KRAS,cancer of unknown primary,Female,1,1000,0.002,0.002,0,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,cancer of unknown primary,Male,4,989,0.003,0.003,0.001,0.008,KRAS_12S,12S,NA
single,Sex,KRAS,non-small cell lung cancer,Female,30,5722,0.005,0.005,0.004,0.007,KRAS_12S,12S,NA
single,Sex,KRAS,non-small cell lung cancer,Male,22,4406,0.005,0.005,0.003,0.007,KRAS_12S,12S,NA
single,Sex,KRAS,breast cancer,Female,6,9284,0.001,0.001,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.001,0.001,0,0.009,KRAS_12S,12S,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,pancreatic cancer,Female,0,1153,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,pancreatic cancer,Male,0,1341,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,leukemia,Female,1,637,0.001,0.001,0,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0.002,KRAS_12S,12S,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,melanoma,Male,1,1742,0.001,0,0,0.002,KRAS_12S,12S,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,uterine cancer,Female,6,2254,0.003,0.003,0.001,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,1,483,0.002,0.002,0,0.006,KRAS_12S,12S,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.002,0.001,0,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_12S,12S,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,ovarian cancer,Female,1,2336,0,0,0,0.002,KRAS_12S,12S,NA
single,Sex,KRAS,esophagogastric cancer,Female,1,504,0.002,0.002,0,0.006,KRAS_12S,12S,NA
single,Sex,KRAS,esophagogastric cancer,Male,3,1297,0.002,0.002,0.001,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,cervical cancer,Female,3,365,0.009,0.008,0.002,0.02,KRAS_12S,12S,NA
single,Sex,KRAS,hepatobiliary cancer,Female,2,636,0.003,0.002,0,0.008,KRAS_12S,12S,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0.001,0,0,0.004,KRAS_12S,12S,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0.001,0,0,0.003,KRAS_12S,12S,NA
single,Sex,KRAS,kidney cancer,Male,1,1002,0.001,0.001,0,0.003,KRAS_12S,12S,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_12S,12S,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_12S,12S,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,bladder cancer,Female,1,393,0.002,0.001,0,0.007,KRAS_12S,12S,NA
single,Sex,KRAS,bladder cancer,Male,1,1188,0.001,0.001,0,0.004,KRAS_12S,12S,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,small bowel cancer,Female,1,78,0.015,0.013,0.002,0.041,KRAS_12S,12S,NA
single,Sex,KRAS,small bowel cancer,Male,2,132,0.015,0.014,0.003,0.038,KRAS_12S,12S,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.002,KRAS_12S,12S,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.004,KRAS_12S,12S,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0.001,0,0,0.006,KRAS_12S,12S,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.005,KRAS_12S,12S,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.004,KRAS_12S,12S,NA
single,Sex,KRAS,ampullary cancer,Female,1,41,0.018,0.012,0.001,0.073,KRAS_12S,12S,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0.007,0.003,0,0.033,KRAS_12S,12S,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_12S,12S,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_12S,12S,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.003,0.002,0,0.011,KRAS_12S,12S,NA
single,Sex,KRAS,germ cell tumor,Male,4,711,0.005,0.005,0.001,0.011,KRAS_12S,12S,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_12S,12S,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_12S,12S,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.003,0,0,0.029,KRAS_12S,12S,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.001,0,0,0.013,KRAS_12S,12S,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.002,0,0,0.026,KRAS_12S,12S,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.003,0.003,0,0.009,KRAS_12S,12S,NA
single,Sex,KRAS,b cell lymphoma,Male,2,567,0.003,0.003,0.001,0.009,KRAS_12S,12S,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.035,KRAS_12S,12S,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.034,KRAS_12S,12S,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.024,0.014,0,0.105,KRAS_12S,12S,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,1,28,0.032,0.024,0.001,0.111,KRAS_12S,12S,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,KRAS_12S,12S,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,KRAS_12S,12S,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.023,KRAS_12S,12S,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,KRAS_12S,12S,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.005,0,0,0.058,KRAS_12S,12S,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,KRAS_12S,12S,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.03,KRAS_12S,12S,NA
single,Sex,KRAS,appendiceal cancer,Female,18,174,0.113,0.113,0.073,0.156,KRAS_12V,12V,NA
single,Sex,KRAS,appendiceal cancer,Male,23,167,0.129,0.127,0.089,0.179,KRAS_12V,12V,NA
single,Sex,KRAS,colorectal cancer,Female,299,3028,0.097,0.097,0.087,0.108,KRAS_12V,12V,NA
single,Sex,KRAS,colorectal cancer,Male,321,3696,0.088,0.088,0.079,0.097,KRAS_12V,12V,NA
single,Sex,KRAS,cancer of unknown primary,Female,58,1000,0.056,0.056,0.044,0.07,KRAS_12V,12V,NA
single,Sex,KRAS,cancer of unknown primary,Male,49,989,0.052,0.052,0.04,0.064,KRAS_12V,12V,NA
single,Sex,KRAS,non-small cell lung cancer,Female,327,5722,0.056,0.056,0.051,0.062,KRAS_12V,12V,NA
single,Sex,KRAS,non-small cell lung cancer,Male,221,4406,0.051,0.051,0.045,0.058,KRAS_12V,12V,NA
single,Sex,KRAS,breast cancer,Female,30,9284,0.003,0.003,0.002,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.003,0.003,0,0.015,KRAS_12V,12V,NA
single,Sex,KRAS,soft tissue sarcoma,Female,2,1413,0.002,0.001,0,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,soft tissue sarcoma,Male,2,1360,0.002,0.001,0,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,pancreatic cancer,Female,257,1153,0.227,0.227,0.204,0.249,KRAS_12V,12V,NA
single,Sex,KRAS,pancreatic cancer,Male,326,1341,0.24,0.24,0.219,0.263,KRAS_12V,12V,NA
single,Sex,KRAS,leukemia,Female,9,637,0.012,0.012,0.006,0.021,KRAS_12V,12V,NA
single,Sex,KRAS,leukemia,Male,7,930,0.009,0.009,0.004,0.015,KRAS_12V,12V,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0.002,KRAS_12V,12V,NA
single,Sex,KRAS,melanoma,Male,2,1742,0.001,0.001,0,0.003,KRAS_12V,12V,NA
single,Sex,KRAS,head and neck cancer,Female,1,564,0.001,0.001,0,0.006,KRAS_12V,12V,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0.002,KRAS_12V,12V,NA
single,Sex,KRAS,uterine cancer,Female,112,2254,0.05,0.05,0.041,0.059,KRAS_12V,12V,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,KRAS_12V,12V,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,KRAS_12V,12V,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,1,483,0.002,0.002,0,0.006,KRAS_12V,12V,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.002,0.001,0,0.005,KRAS_12V,12V,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,KRAS_12V,12V,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,KRAS_12V,12V,NA
single,Sex,KRAS,ovarian cancer,Female,83,2336,0.036,0.035,0.028,0.044,KRAS_12V,12V,NA
single,Sex,KRAS,esophagogastric cancer,Female,4,504,0.008,0.008,0.004,0.015,KRAS_12V,12V,NA
single,Sex,KRAS,esophagogastric cancer,Male,11,1297,0.008,0.008,0.005,0.014,KRAS_12V,12V,NA
single,Sex,KRAS,thyroid cancer,Female,1,537,0.004,0.004,0,0.01,KRAS_12V,12V,NA
single,Sex,KRAS,thyroid cancer,Male,5,480,0.009,0.008,0.003,0.019,KRAS_12V,12V,NA
single,Sex,KRAS,cervical cancer,Female,11,365,0.031,0.03,0.016,0.051,KRAS_12V,12V,NA
single,Sex,KRAS,hepatobiliary cancer,Female,17,636,0.027,0.027,0.018,0.039,KRAS_12V,12V,NA
single,Sex,KRAS,hepatobiliary cancer,Male,21,739,0.028,0.028,0.019,0.039,KRAS_12V,12V,NA
single,Sex,KRAS,kidney cancer,Female,1,420,0.003,0.003,0,0.007,KRAS_12V,12V,NA
single,Sex,KRAS,kidney cancer,Male,3,1002,0.003,0.003,0.001,0.007,KRAS_12V,12V,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,1,107,0.007,0.005,0,0.028,KRAS_12V,12V,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0.004,0.002,0,0.016,KRAS_12V,12V,NA
single,Sex,KRAS,cns cancer,Female,4,1994,0.002,0.002,0.001,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,cns cancer,Male,4,2569,0.002,0.002,0.001,0.003,KRAS_12V,12V,NA
single,Sex,KRAS,prostate cancer,Male,2,2436,0.001,0.001,0,0.002,KRAS_12V,12V,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.005,KRAS_12V,12V,NA
single,Sex,KRAS,neuroendocrine tumors,Female,2,166,0.016,0.015,0.004,0.034,KRAS_12V,12V,NA
single,Sex,KRAS,neuroendocrine tumors,Male,4,193,0.019,0.017,0.006,0.038,KRAS_12V,12V,NA
single,Sex,KRAS,bladder cancer,Female,5,393,0.013,0.012,0.006,0.022,KRAS_12V,12V,NA
single,Sex,KRAS,bladder cancer,Male,14,1188,0.012,0.012,0.007,0.018,KRAS_12V,12V,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.007,0.005,0,0.029,KRAS_12V,12V,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0.003,0.002,0,0.015,KRAS_12V,12V,NA
single,Sex,KRAS,small bowel cancer,Female,13,78,0.144,0.139,0.085,0.232,KRAS_12V,12V,NA
single,Sex,KRAS,small bowel cancer,Male,12,132,0.106,0.105,0.058,0.158,KRAS_12V,12V,NA
single,Sex,KRAS,sex cord stromal tumor,Female,2,97,0.02,0.017,0.003,0.054,KRAS_12V,12V,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.019,0.013,0,0.078,KRAS_12V,12V,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_12V,12V,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_12V,12V,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.005,KRAS_12V,12V,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_12V,12V,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.002,KRAS_12V,12V,NA
single,Sex,KRAS,ampullary cancer,Female,3,41,0.099,0.097,0.031,0.179,KRAS_12V,12V,NA
single,Sex,KRAS,ampullary cancer,Male,9,65,0.124,0.12,0.063,0.207,KRAS_12V,12V,NA
single,Sex,KRAS,small cell lung cancer,Female,2,193,0.009,0.008,0.002,0.023,KRAS_12V,12V,NA
single,Sex,KRAS,small cell lung cancer,Male,1,205,0.007,0.006,0.001,0.019,KRAS_12V,12V,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.002,KRAS_12V,12V,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_12V,12V,NA
single,Sex,KRAS,germ cell tumor,Female,2,175,0.017,0.017,0.004,0.033,KRAS_12V,12V,NA
single,Sex,KRAS,germ cell tumor,Male,16,711,0.021,0.021,0.013,0.033,KRAS_12V,12V,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,KRAS_12V,12V,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.022,KRAS_12V,12V,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.023,KRAS_12V,12V,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.002,0,0,0.029,KRAS_12V,12V,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.004,0.004,0.001,0.01,KRAS_12V,12V,NA
single,Sex,KRAS,b cell lymphoma,Male,3,567,0.005,0.004,0.001,0.011,KRAS_12V,12V,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,KRAS_12V,12V,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.03,KRAS_12V,12V,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.021,KRAS_12V,12V,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.016,KRAS_12V,12V,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,KRAS_12V,12V,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.01,KRAS_12V,12V,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.022,KRAS_12V,12V,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,KRAS_12V,12V,NA
single,Sex,KRAS,lung cancer,Male,1,16,0.069,0.052,0.003,0.229,KRAS_12V,12V,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,KRAS_12V,12V,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.039,KRAS_12V,12V,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,colorectal cancer,Female,15,3028,0.004,0.004,0.002,0.007,KRAS_13C,13C,NA
single,Sex,KRAS,colorectal cancer,Male,9,3696,0.003,0.003,0.001,0.005,KRAS_13C,13C,NA
single,Sex,KRAS,cancer of unknown primary,Female,3,1000,0.004,0.004,0.001,0.008,KRAS_13C,13C,NA
single,Sex,KRAS,cancer of unknown primary,Male,5,989,0.005,0.004,0.002,0.009,KRAS_13C,13C,NA
single,Sex,KRAS,non-small cell lung cancer,Female,70,5722,0.012,0.012,0.009,0.015,KRAS_13C,13C,NA
single,Sex,KRAS,non-small cell lung cancer,Male,39,4406,0.01,0.01,0.007,0.012,KRAS_13C,13C,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,soft tissue sarcoma,Male,1,1360,0.001,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,pancreatic cancer,Female,0,1153,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,pancreatic cancer,Male,0,1341,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,leukemia,Female,0,637,0.001,0,0,0.003,KRAS_13C,13C,NA
single,Sex,KRAS,leukemia,Male,1,930,0.001,0.001,0,0.003,KRAS_13C,13C,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,uterine cancer,Female,5,2254,0.002,0.002,0.001,0.005,KRAS_13C,13C,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,KRAS_13C,13C,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,KRAS_13C,13C,NA
single,Sex,KRAS,ovarian cancer,Female,1,2336,0.001,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_13C,13C,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,anal cancer,Female,1,102,0.009,0.007,0,0.032,KRAS_13C,13C,NA
single,Sex,KRAS,anal cancer,Male,0,47,0.007,0.004,0,0.03,KRAS_13C,13C,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.006,KRAS_13C,13C,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.013,KRAS_13C,13C,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,vaginal cancer,Female,1,78,0.015,0.011,0.001,0.051,KRAS_13C,13C,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.005,KRAS_13C,13C,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.005,KRAS_13C,13C,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0,0,0,0.005,KRAS_13C,13C,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0,0,0,0.004,KRAS_13C,13C,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0.001,KRAS_13C,13C,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_13C,13C,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.002,KRAS_13C,13C,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.001,0,0,0.008,KRAS_13C,13C,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,KRAS_13C,13C,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.003,0,0,0.042,KRAS_13C,13C,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.002,0.001,0,0.008,KRAS_13C,13C,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0.001,0,0,0.004,KRAS_13C,13C,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.026,KRAS_13C,13C,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,KRAS_13C,13C,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,KRAS_13C,13C,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,KRAS_13C,13C,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,KRAS_13C,13C,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,KRAS_13C,13C,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,KRAS_13C,13C,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,KRAS_13C,13C,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.042,KRAS_13C,13C,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,KRAS_13C,13C,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,KRAS_13C,13C,NA
single,Sex,KRAS,appendiceal cancer,Female,6,174,0.039,0.038,0.018,0.066,KRAS_13D,13D,NA
single,Sex,KRAS,appendiceal cancer,Male,8,167,0.044,0.042,0.022,0.074,KRAS_13D,13D,NA
single,Sex,KRAS,colorectal cancer,Female,236,3028,0.077,0.077,0.068,0.086,KRAS_13D,13D,NA
single,Sex,KRAS,colorectal cancer,Male,265,3696,0.073,0.073,0.065,0.081,KRAS_13D,13D,NA
single,Sex,KRAS,cancer of unknown primary,Female,11,1000,0.012,0.012,0.007,0.019,KRAS_13D,13D,NA
single,Sex,KRAS,cancer of unknown primary,Male,15,989,0.014,0.014,0.009,0.021,KRAS_13D,13D,NA
single,Sex,KRAS,non-small cell lung cancer,Female,48,5722,0.009,0.008,0.007,0.011,KRAS_13D,13D,NA
single,Sex,KRAS,non-small cell lung cancer,Male,39,4406,0.009,0.009,0.007,0.011,KRAS_13D,13D,NA
single,Sex,KRAS,breast cancer,Female,4,9284,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,breast cancer,Male,1,48,0.014,0.007,0,0.065,KRAS_13D,13D,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,pancreatic cancer,Female,6,1153,0.006,0.005,0.003,0.009,KRAS_13D,13D,NA
single,Sex,KRAS,pancreatic cancer,Male,8,1341,0.006,0.006,0.003,0.01,KRAS_13D,13D,NA
single,Sex,KRAS,leukemia,Female,11,637,0.017,0.016,0.01,0.026,KRAS_13D,13D,NA
single,Sex,KRAS,leukemia,Male,14,930,0.016,0.015,0.009,0.023,KRAS_13D,13D,NA
single,Sex,KRAS,melanoma,Female,2,1104,0.002,0.002,0.001,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,melanoma,Male,5,1742,0.003,0.003,0.001,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,head and neck cancer,Female,1,564,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,head and neck cancer,Male,2,1179,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,uterine cancer,Female,46,2254,0.02,0.02,0.015,0.027,KRAS_13D,13D,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,4,483,0.007,0.006,0.002,0.015,KRAS_13D,13D,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,3,724,0.005,0.005,0.002,0.011,KRAS_13D,13D,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,KRAS_13D,13D,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,KRAS_13D,13D,NA
single,Sex,KRAS,ovarian cancer,Female,10,2336,0.004,0.004,0.002,0.007,KRAS_13D,13D,NA
single,Sex,KRAS,esophagogastric cancer,Female,8,504,0.014,0.013,0.007,0.024,KRAS_13D,13D,NA
single,Sex,KRAS,esophagogastric cancer,Male,14,1297,0.012,0.012,0.007,0.018,KRAS_13D,13D,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,cervical cancer,Female,4,365,0.012,0.011,0.003,0.025,KRAS_13D,13D,NA
single,Sex,KRAS,hepatobiliary cancer,Female,3,636,0.006,0.006,0.002,0.012,KRAS_13D,13D,NA
single,Sex,KRAS,hepatobiliary cancer,Male,6,739,0.007,0.007,0.003,0.014,KRAS_13D,13D,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_13D,13D,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_13D,13D,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_13D,13D,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_13D,13D,NA
single,Sex,KRAS,anal cancer,Female,1,102,0.009,0.007,0,0.032,KRAS_13D,13D,NA
single,Sex,KRAS,anal cancer,Male,0,47,0.007,0.004,0,0.03,KRAS_13D,13D,NA
single,Sex,KRAS,neuroendocrine tumors,Female,2,166,0.016,0.015,0.004,0.033,KRAS_13D,13D,NA
single,Sex,KRAS,neuroendocrine tumors,Male,4,193,0.018,0.017,0.006,0.038,KRAS_13D,13D,NA
single,Sex,KRAS,bladder cancer,Female,2,393,0.004,0.003,0.001,0.011,KRAS_13D,13D,NA
single,Sex,KRAS,bladder cancer,Male,2,1188,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,2,106,0.028,0.026,0.006,0.057,KRAS_13D,13D,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,6,142,0.037,0.035,0.015,0.071,KRAS_13D,13D,NA
single,Sex,KRAS,small bowel cancer,Female,3,78,0.054,0.053,0.016,0.099,KRAS_13D,13D,NA
single,Sex,KRAS,small bowel cancer,Male,10,132,0.068,0.066,0.036,0.114,KRAS_13D,13D,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.006,KRAS_13D,13D,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.013,KRAS_13D,13D,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0.001,0,0,0.008,KRAS_13D,13D,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,ampullary cancer,Female,3,41,0.058,0.052,0.016,0.134,KRAS_13D,13D,NA
single,Sex,KRAS,ampullary cancer,Male,2,65,0.043,0.04,0.01,0.094,KRAS_13D,13D,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_13D,13D,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.001,0,0,0.006,KRAS_13D,13D,NA
single,Sex,KRAS,germ cell tumor,Male,1,711,0.001,0.001,0,0.005,KRAS_13D,13D,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.002,KRAS_13D,13D,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.002,KRAS_13D,13D,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.001,0,0,0.008,KRAS_13D,13D,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,KRAS_13D,13D,NA
single,Sex,KRAS,pineal tumor,Male,1,12,0.092,0.071,0.004,0.295,KRAS_13D,13D,NA
single,Sex,KRAS,b cell lymphoma,Female,5,395,0.01,0.009,0.004,0.022,KRAS_13D,13D,NA
single,Sex,KRAS,b cell lymphoma,Male,2,567,0.006,0.005,0.001,0.013,KRAS_13D,13D,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.026,KRAS_13D,13D,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,KRAS_13D,13D,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,KRAS_13D,13D,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,KRAS_13D,13D,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,KRAS_13D,13D,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,KRAS_13D,13D,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,KRAS_13D,13D,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,KRAS_13D,13D,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.042,KRAS_13D,13D,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,KRAS_13D,13D,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,KRAS_13D,13D,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,colorectal cancer,Female,1,3028,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,colorectal cancer,Male,1,3696,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,cancer of unknown primary,Female,1,1000,0.001,0.001,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,cancer of unknown primary,Male,0,989,0,0,0,0.002,KRAS_13R,13R,NA
single,Sex,KRAS,non-small cell lung cancer,Female,4,5722,0.001,0.001,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,non-small cell lung cancer,Male,2,4406,0.001,0.001,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,pancreatic cancer,Female,0,1153,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,pancreatic cancer,Male,0,1341,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,leukemia,Female,0,637,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,uterine cancer,Female,0,2254,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_13R,13R,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,KRAS_13R,13R,NA
single,Sex,KRAS,ovarian cancer,Female,0,2336,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,cns cancer,Male,1,2569,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.004,KRAS_13R,13R,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,KRAS_13R,13R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,KRAS_13R,13R,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.007,KRAS_13R,13R,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0.001,0,0,0.007,KRAS_13R,13R,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.003,KRAS_13R,13R,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,KRAS_13R,13R,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,KRAS_13R,13R,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0.001,KRAS_13R,13R,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.005,KRAS_13R,13R,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.005,KRAS_13R,13R,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.001,0,0,0.018,KRAS_13R,13R,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,KRAS_13R,13R,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.005,0,0,0.059,KRAS_13R,13R,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0,0,0,0,KRAS_13R,13R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.023,KRAS_13R,13R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,KRAS_13R,13R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.013,KRAS_13R,13R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.01,KRAS_13R,13R,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.011,KRAS_13R,13R,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,KRAS_13R,13R,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,KRAS_13R,13R,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.017,KRAS_13R,13R,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.035,KRAS_13R,13R,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.07,KRAS_13R,13R,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.033,KRAS_13R,13R,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,colorectal cancer,Female,0,3028,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,colorectal cancer,Male,2,3696,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,cancer of unknown primary,Male,0,989,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,non-small cell lung cancer,Female,2,5722,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,non-small cell lung cancer,Male,2,4406,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,pancreatic cancer,Female,0,1153,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,pancreatic cancer,Male,2,1341,0.001,0.001,0,0.004,KRAS_13V,13V,NA
single,Sex,KRAS,leukemia,Female,0,637,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,uterine cancer,Female,0,2254,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_13V,13V,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,KRAS_13V,13V,NA
single,Sex,KRAS,ovarian cancer,Female,0,2336,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,cns cancer,Male,0,2569,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,prostate cancer,Male,0,2436,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.004,KRAS_13V,13V,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.005,KRAS_13V,13V,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.004,KRAS_13V,13V,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.006,KRAS_13V,13V,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_13V,13V,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.002,KRAS_13V,13V,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0,0,0,0.006,KRAS_13V,13V,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0,0,0,0.005,KRAS_13V,13V,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_13V,13V,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0.001,0.001,0,0.006,KRAS_13V,13V,NA
single,Sex,KRAS,germ cell tumor,Male,1,711,0.001,0.001,0,0.005,KRAS_13V,13V,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_13V,13V,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_13V,13V,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.027,KRAS_13V,13V,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,KRAS_13V,13V,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,KRAS_13V,13V,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0,0,0,0,KRAS_13V,13V,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,KRAS_13V,13V,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,KRAS_13V,13V,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,KRAS_13V,13V,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,KRAS_13V,13V,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,KRAS_13V,13V,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,KRAS_13V,13V,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,KRAS_13V,13V,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,KRAS_13V,13V,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.035,KRAS_13V,13V,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,KRAS_13V,13V,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,KRAS_13V,13V,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0.003,0.001,0,0.016,KRAS_61H,61H,NA
single,Sex,KRAS,appendiceal cancer,Male,3,167,0.016,0.013,0.003,0.04,KRAS_61H,61H,NA
single,Sex,KRAS,colorectal cancer,Female,29,3028,0.01,0.01,0.007,0.013,KRAS_61H,61H,NA
single,Sex,KRAS,colorectal cancer,Male,35,3696,0.01,0.009,0.007,0.012,KRAS_61H,61H,NA
single,Sex,KRAS,cancer of unknown primary,Female,8,1000,0.008,0.008,0.004,0.013,KRAS_61H,61H,NA
single,Sex,KRAS,cancer of unknown primary,Male,7,989,0.008,0.007,0.004,0.013,KRAS_61H,61H,NA
single,Sex,KRAS,non-small cell lung cancer,Female,84,5722,0.014,0.014,0.011,0.017,KRAS_61H,61H,NA
single,Sex,KRAS,non-small cell lung cancer,Male,47,4406,0.011,0.011,0.008,0.015,KRAS_61H,61H,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,soft tissue sarcoma,Female,1,1413,0.001,0,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,pancreatic cancer,Female,38,1153,0.034,0.034,0.025,0.043,KRAS_61H,61H,NA
single,Sex,KRAS,pancreatic cancer,Male,48,1341,0.035,0.035,0.027,0.044,KRAS_61H,61H,NA
single,Sex,KRAS,leukemia,Female,2,637,0.003,0.003,0.001,0.007,KRAS_61H,61H,NA
single,Sex,KRAS,leukemia,Male,2,930,0.003,0.002,0.001,0.006,KRAS_61H,61H,NA
single,Sex,KRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,KRAS_61H,61H,NA
single,Sex,KRAS,melanoma,Male,1,1742,0.001,0.001,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,uterine cancer,Female,6,2254,0.003,0.003,0.001,0.005,KRAS_61H,61H,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_61H,61H,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,KRAS_61H,61H,NA
single,Sex,KRAS,ovarian cancer,Female,9,2336,0.004,0.004,0.002,0.007,KRAS_61H,61H,NA
single,Sex,KRAS,esophagogastric cancer,Female,1,504,0.002,0.001,0,0.005,KRAS_61H,61H,NA
single,Sex,KRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,KRAS_61H,61H,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,hepatobiliary cancer,Female,7,636,0.011,0.01,0.005,0.018,KRAS_61H,61H,NA
single,Sex,KRAS,hepatobiliary cancer,Male,7,739,0.01,0.01,0.005,0.017,KRAS_61H,61H,NA
single,Sex,KRAS,kidney cancer,Female,1,420,0.002,0.001,0,0.007,KRAS_61H,61H,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,1,107,0.01,0.008,0.001,0.029,KRAS_61H,61H,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,1,124,0.009,0.008,0.001,0.027,KRAS_61H,61H,NA
single,Sex,KRAS,cns cancer,Female,1,1994,0.001,0.001,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,cns cancer,Male,2,2569,0.001,0.001,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.004,KRAS_61H,61H,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.005,KRAS_61H,61H,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0.002,0.001,0,0.011,KRAS_61H,61H,NA
single,Sex,KRAS,neuroendocrine tumors,Male,1,193,0.004,0.003,0,0.016,KRAS_61H,61H,NA
single,Sex,KRAS,bladder cancer,Female,2,393,0.004,0.003,0.001,0.011,KRAS_61H,61H,NA
single,Sex,KRAS,bladder cancer,Male,1,1188,0.002,0.001,0,0.004,KRAS_61H,61H,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.012,0.011,0.001,0.033,KRAS_61H,61H,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,2,142,0.014,0.012,0.003,0.033,KRAS_61H,61H,NA
single,Sex,KRAS,small bowel cancer,Female,4,78,0.04,0.035,0.012,0.091,KRAS_61H,61H,NA
single,Sex,KRAS,small bowel cancer,Male,2,132,0.024,0.022,0.005,0.052,KRAS_61H,61H,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.004,KRAS_61H,61H,NA
single,Sex,KRAS,bone cancer,Female,1,242,0.003,0.002,0,0.013,KRAS_61H,61H,NA
single,Sex,KRAS,bone cancer,Male,0,328,0.001,0,0,0.006,KRAS_61H,61H,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.006,KRAS_61H,61H,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_61H,61H,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.002,KRAS_61H,61H,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0.013,0.009,0,0.05,KRAS_61H,61H,NA
single,Sex,KRAS,ampullary cancer,Male,2,65,0.025,0.021,0.004,0.072,KRAS_61H,61H,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_61H,61H,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_61H,61H,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_61H,61H,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_61H,61H,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.027,KRAS_61H,61H,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,KRAS_61H,61H,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,KRAS_61H,61H,NA
single,Sex,KRAS,b cell lymphoma,Female,4,395,0.011,0.01,0.004,0.02,KRAS_61H,61H,NA
single,Sex,KRAS,b cell lymphoma,Male,6,567,0.011,0.01,0.005,0.019,KRAS_61H,61H,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,KRAS_61H,61H,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,KRAS_61H,61H,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,KRAS_61H,61H,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,KRAS_61H,61H,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,KRAS_61H,61H,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,KRAS_61H,61H,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,KRAS_61H,61H,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,KRAS_61H,61H,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.035,KRAS_61H,61H,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,KRAS_61H,61H,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,KRAS_61H,61H,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,colorectal cancer,Female,9,3028,0.003,0.002,0.001,0.005,KRAS_61K,61K,NA
single,Sex,KRAS,colorectal cancer,Male,3,3696,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,cancer of unknown primary,Female,1,1000,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,cancer of unknown primary,Male,0,989,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,non-small cell lung cancer,Male,1,4406,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,breast cancer,Female,0,9284,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,breast cancer,Male,0,48,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,pancreatic cancer,Female,2,1153,0.001,0.001,0,0.004,KRAS_61K,61K,NA
single,Sex,KRAS,pancreatic cancer,Male,1,1341,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,leukemia,Female,0,637,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,leukemia,Male,0,930,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,melanoma,Female,0,1104,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,melanoma,Male,0,1742,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,uterine cancer,Female,1,2254,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,ovarian cancer,Female,1,2336,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,thyroid cancer,Female,1,537,0.002,0.001,0,0.006,KRAS_61K,61K,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0.001,0,0,0.004,KRAS_61K,61K,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,cns cancer,Female,1,1994,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,cns cancer,Male,1,2569,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,anal cancer,Female,1,102,0.009,0.007,0,0.031,KRAS_61K,61K,NA
single,Sex,KRAS,anal cancer,Male,0,47,0.007,0.004,0,0.029,KRAS_61K,61K,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0.002,0.001,0,0.011,KRAS_61K,61K,NA
single,Sex,KRAS,neuroendocrine tumors,Male,1,193,0.004,0.003,0,0.016,KRAS_61K,61K,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.002,KRAS_61K,61K,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.004,KRAS_61K,61K,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.01,KRAS_61K,61K,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.006,KRAS_61K,61K,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.003,KRAS_61K,61K,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0.001,0,0,0.008,KRAS_61K,61K,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,KRAS_61K,61K,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_61K,61K,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,KRAS_61K,61K,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.005,KRAS_61K,61K,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.019,KRAS_61K,61K,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.024,KRAS_61K,61K,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.003,0,0,0.029,KRAS_61K,61K,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0,0,0,0,KRAS_61K,61K,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.037,KRAS_61K,61K,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.038,KRAS_61K,61K,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.018,KRAS_61K,61K,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,KRAS_61K,61K,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.002,0,0,0.019,KRAS_61K,61K,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.017,KRAS_61K,61K,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.026,KRAS_61K,61K,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.023,KRAS_61K,61K,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.038,KRAS_61K,61K,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.067,KRAS_61K,61K,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,KRAS_61K,61K,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0.002,0.001,0,0.011,KRAS_61L,61L,NA
single,Sex,KRAS,appendiceal cancer,Male,1,167,0.005,0.003,0,0.018,KRAS_61L,61L,NA
single,Sex,KRAS,colorectal cancer,Female,15,3028,0.004,0.004,0.003,0.007,KRAS_61L,61L,NA
single,Sex,KRAS,colorectal cancer,Male,9,3696,0.003,0.003,0.001,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,cancer of unknown primary,Female,2,1000,0.002,0.002,0,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,cancer of unknown primary,Male,1,989,0.001,0.001,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,non-small cell lung cancer,Female,23,5722,0.004,0.004,0.003,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,non-small cell lung cancer,Male,14,4406,0.003,0.003,0.002,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,breast cancer,Female,1,9284,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.001,0,0,0.007,KRAS_61L,61L,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,pancreatic cancer,Female,5,1153,0.004,0.003,0.001,0.008,KRAS_61L,61L,NA
single,Sex,KRAS,pancreatic cancer,Male,1,1341,0.002,0.001,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,leukemia,Female,0,637,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,leukemia,Male,1,930,0.001,0.001,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,melanoma,Male,1,1742,0.001,0.001,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,uterine cancer,Female,2,2254,0.001,0.001,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,ovarian cancer,Female,1,2336,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,esophagogastric cancer,Female,0,504,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,thyroid cancer,Female,0,537,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,thyroid cancer,Male,0,480,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,hepatobiliary cancer,Female,1,636,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,hepatobiliary cancer,Male,1,739,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,cns cancer,Female,0,1994,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,cns cancer,Male,2,2569,0.001,0.001,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,bladder cancer,Female,1,393,0.002,0.001,0,0.008,KRAS_61L,61L,NA
single,Sex,KRAS,bladder cancer,Male,0,1188,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.006,KRAS_61L,61L,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.002,KRAS_61L,61L,NA
single,Sex,KRAS,ampullary cancer,Female,0,41,0,0,0,0.006,KRAS_61L,61L,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0,0,0,0.005,KRAS_61L,61L,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_61L,61L,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_61L,61L,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,KRAS_61L,61L,NA
single,Sex,KRAS,penile cancer,Male,1,25,0.045,0.034,0.002,0.151,KRAS_61L,61L,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,KRAS_61L,61L,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,KRAS_61L,61L,NA
single,Sex,KRAS,b cell lymphoma,Female,1,395,0.002,0.001,0,0.008,KRAS_61L,61L,NA
single,Sex,KRAS,b cell lymphoma,Male,0,567,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,KRAS_61L,61L,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,KRAS_61L,61L,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,KRAS_61L,61L,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,KRAS_61L,61L,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,KRAS_61L,61L,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,KRAS_61L,61L,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,KRAS_61L,61L,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,KRAS_61L,61L,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.003,0,0,0.035,KRAS_61L,61L,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,KRAS_61L,61L,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,KRAS_61L,61L,NA
single,Sex,KRAS,appendiceal cancer,Female,0,174,0.002,0.001,0,0.011,KRAS_61R,61R,NA
single,Sex,KRAS,appendiceal cancer,Male,1,167,0.005,0.003,0,0.018,KRAS_61R,61R,NA
single,Sex,KRAS,colorectal cancer,Female,8,3028,0.003,0.003,0.002,0.005,KRAS_61R,61R,NA
single,Sex,KRAS,colorectal cancer,Male,12,3696,0.003,0.003,0.002,0.005,KRAS_61R,61R,NA
single,Sex,KRAS,cancer of unknown primary,Female,1,1000,0.001,0.001,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,cancer of unknown primary,Male,2,989,0.002,0.002,0,0.005,KRAS_61R,61R,NA
single,Sex,KRAS,non-small cell lung cancer,Female,5,5722,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,non-small cell lung cancer,Male,2,4406,0.001,0.001,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,breast cancer,Female,1,9284,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,breast cancer,Male,0,48,0.001,0,0,0.009,KRAS_61R,61R,NA
single,Sex,KRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,pancreatic cancer,Female,16,1153,0.015,0.015,0.009,0.021,KRAS_61R,61R,NA
single,Sex,KRAS,pancreatic cancer,Male,22,1341,0.016,0.016,0.011,0.022,KRAS_61R,61R,NA
single,Sex,KRAS,leukemia,Female,0,637,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,leukemia,Male,1,930,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,melanoma,Female,2,1104,0.001,0.001,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,melanoma,Male,1,1742,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,head and neck cancer,Female,0,564,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,head and neck cancer,Male,0,1179,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,uterine cancer,Female,0,2254,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,ovarian cancer,Female,2,2336,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,esophagogastric cancer,Female,1,504,0.002,0.001,0,0.006,KRAS_61R,61R,NA
single,Sex,KRAS,esophagogastric cancer,Male,0,1297,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,thyroid cancer,Female,9,537,0.016,0.015,0.008,0.026,KRAS_61R,61R,NA
single,Sex,KRAS,thyroid cancer,Male,6,480,0.014,0.014,0.007,0.024,KRAS_61R,61R,NA
single,Sex,KRAS,cervical cancer,Female,0,365,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,hepatobiliary cancer,Female,2,636,0.003,0.002,0,0.008,KRAS_61R,61R,NA
single,Sex,KRAS,hepatobiliary cancer,Male,0,739,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,kidney cancer,Female,0,420,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,kidney cancer,Male,0,1002,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,cns cancer,Female,1,1994,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,cns cancer,Male,3,2569,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,prostate cancer,Male,1,2436,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,anal cancer,Female,0,102,0,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,anal cancer,Male,0,47,0,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,bladder cancer,Female,0,393,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,bladder cancer,Male,1,1188,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,small bowel cancer,Female,0,78,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,small bowel cancer,Male,0,132,0,0,0,0.002,KRAS_61R,61R,NA
single,Sex,KRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,sex cord stromal tumor,Male,0,11,0.001,0,0,0.008,KRAS_61R,61R,NA
single,Sex,KRAS,bone cancer,Female,0,242,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,bone cancer,Male,0,328,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,vaginal cancer,Female,0,78,0,0,0,0.005,KRAS_61R,61R,NA
single,Sex,KRAS,thymic tumor,Female,0,70,0,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,thymic tumor,Male,0,86,0,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,ampullary cancer,Female,2,41,0.039,0.031,0.004,0.115,KRAS_61R,61R,NA
single,Sex,KRAS,ampullary cancer,Male,0,65,0.009,0.004,0,0.042,KRAS_61R,61R,NA
single,Sex,KRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,mesothelioma,Female,0,145,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,mesothelioma,Male,0,352,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,germ cell tumor,Female,0,175,0,0,0,0.001,KRAS_61R,61R,NA
single,Sex,KRAS,germ cell tumor,Male,0,711,0,0,0,0,KRAS_61R,61R,NA
single,Sex,KRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,KRAS_61R,61R,NA
single,Sex,KRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,KRAS_61R,61R,NA
single,Sex,KRAS,penile cancer,Male,0,25,0.002,0,0,0.023,KRAS_61R,61R,NA
single,Sex,KRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.033,KRAS_61R,61R,NA
single,Sex,KRAS,pineal tumor,Male,0,12,0.003,0,0,0.04,KRAS_61R,61R,NA
single,Sex,KRAS,b cell lymphoma,Female,0,395,0.002,0.001,0,0.007,KRAS_61R,61R,NA
single,Sex,KRAS,b cell lymphoma,Male,3,567,0.005,0.004,0.001,0.011,KRAS_61R,61R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.036,KRAS_61R,61R,NA
single,Sex,KRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.035,KRAS_61R,61R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.016,KRAS_61R,61R,NA
single,Sex,KRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.013,KRAS_61R,61R,NA
single,Sex,KRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,KRAS_61R,61R,NA
single,Sex,KRAS,retinoblastoma,Male,0,28,0.001,0,0,0.012,KRAS_61R,61R,NA
single,Sex,KRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,KRAS_61R,61R,NA
single,Sex,KRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,KRAS_61R,61R,NA
single,Sex,KRAS,lung cancer,Male,0,16,0.002,0,0,0.026,KRAS_61R,61R,NA
single,Sex,KRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.047,KRAS_61R,61R,NA
single,Sex,KRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.027,KRAS_61R,61R,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,head and neck cancer,Female,1,564,0.001,0.001,0,0.006,HRAS_12A,12A,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0.002,HRAS_12A,12A,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.002,HRAS_12A,12A,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.002,HRAS_12A,12A,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.005,HRAS_12A,12A,NA
single,Sex,HRAS,anal cancer,Male,0,47,0.001,0,0,0.006,HRAS_12A,12A,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.003,HRAS_12A,12A,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.003,HRAS_12A,12A,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.006,HRAS_12A,12A,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.013,HRAS_12A,12A,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.005,HRAS_12A,12A,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_12A,12A,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_12A,12A,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.006,HRAS_12A,12A,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.005,HRAS_12A,12A,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_12A,12A,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_12A,12A,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_12A,12A,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_12A,12A,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.003,0,0,0.029,HRAS_12A,12A,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.041,HRAS_12A,12A,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.005,0,0,0.057,HRAS_12A,12A,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12A,12A,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.001,0,0,0.016,HRAS_12A,12A,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.001,0,0,0.016,HRAS_12A,12A,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.025,HRAS_12A,12A,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,HRAS_12A,12A,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.008,HRAS_12A,12A,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.008,HRAS_12A,12A,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.016,HRAS_12A,12A,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.014,HRAS_12A,12A,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.001,0,0,0.015,HRAS_12A,12A,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.055,HRAS_12A,12A,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.038,HRAS_12A,12A,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,breast cancer,Female,2,9283,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.008,HRAS_12C,12C,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,HRAS_12C,12C,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,HRAS_12C,12C,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,HRAS_12C,12C,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,HRAS_12C,12C,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.004,HRAS_12C,12C,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,bladder cancer,Female,1,393,0.002,0.002,0,0.007,HRAS_12C,12C,NA
single,Sex,HRAS,bladder cancer,Male,2,1187,0.002,0.002,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_12C,12C,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_12C,12C,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12C,12C,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_12C,12C,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0.001,0,0,0.007,HRAS_12C,12C,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.002,0,0,0.015,HRAS_12C,12C,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.004,HRAS_12C,12C,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.004,HRAS_12C,12C,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.006,HRAS_12C,12C,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,small cell lung cancer,Female,1,193,0.004,0.003,0,0.015,HRAS_12C,12C,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0.002,0.001,0,0.01,HRAS_12C,12C,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_12C,12C,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_12C,12C,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.025,HRAS_12C,12C,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.037,HRAS_12C,12C,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.04,HRAS_12C,12C,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12C,12C,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.034,HRAS_12C,12C,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.036,HRAS_12C,12C,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.022,HRAS_12C,12C,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.018,HRAS_12C,12C,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.008,HRAS_12C,12C,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.009,HRAS_12C,12C,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,HRAS_12C,12C,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,HRAS_12C,12C,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.041,HRAS_12C,12C,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.005,0,0,0.053,HRAS_12C,12C,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.001,0,0,0.008,HRAS_12C,12C,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,colorectal cancer,Female,2,3026,0.001,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,colorectal cancer,Male,1,3694,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,breast cancer,Female,3,9283,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.008,HRAS_12D,12D,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,melanoma,Female,3,1104,0.003,0.002,0.001,0.006,HRAS_12D,12D,NA
single,Sex,HRAS,melanoma,Male,4,1742,0.002,0.002,0.001,0.005,HRAS_12D,12D,NA
single,Sex,HRAS,head and neck cancer,Female,1,564,0.002,0.001,0,0.005,HRAS_12D,12D,NA
single,Sex,HRAS,head and neck cancer,Male,1,1179,0.001,0.001,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,uterine cancer,Female,2,2248,0.001,0.001,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,HRAS_12D,12D,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,HRAS_12D,12D,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,HRAS_12D,12D,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,HRAS_12D,12D,NA
single,Sex,HRAS,soft tissue sarcoma,Female,1,1400,0.001,0,0,0.002,HRAS_12D,12D,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,thyroid cancer,Female,1,537,0.002,0.001,0,0.006,HRAS_12D,12D,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0.001,0,0,0.004,HRAS_12D,12D,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.002,HRAS_12D,12D,NA
single,Sex,HRAS,bladder cancer,Female,2,393,0.006,0.005,0.002,0.012,HRAS_12D,12D,NA
single,Sex,HRAS,bladder cancer,Male,7,1187,0.006,0.006,0.003,0.011,HRAS_12D,12D,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12D,12D,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_12D,12D,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.011,HRAS_12D,12D,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.004,HRAS_12D,12D,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_12D,12D,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_12D,12D,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.003,HRAS_12D,12D,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.014,HRAS_12D,12D,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,HRAS_12D,12D,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,HRAS_12D,12D,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12D,12D,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,HRAS_12D,12D,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,HRAS_12D,12D,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,HRAS_12D,12D,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,HRAS_12D,12D,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,HRAS_12D,12D,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,HRAS_12D,12D,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,HRAS_12D,12D,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,HRAS_12D,12D,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.037,HRAS_12D,12D,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,HRAS_12D,12D,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,HRAS_12D,12D,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,HRAS_12F,12F,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,HRAS_12F,12F,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.002,HRAS_12F,12F,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0.001,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,bladder cancer,Male,1,1187,0.001,0.001,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12F,12F,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_12F,12F,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.011,HRAS_12F,12F,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.004,HRAS_12F,12F,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_12F,12F,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_12F,12F,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.003,HRAS_12F,12F,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.014,HRAS_12F,12F,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,HRAS_12F,12F,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,HRAS_12F,12F,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12F,12F,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,HRAS_12F,12F,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,HRAS_12F,12F,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,HRAS_12F,12F,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,HRAS_12F,12F,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,HRAS_12F,12F,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,HRAS_12F,12F,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,HRAS_12F,12F,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,HRAS_12F,12F,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.037,HRAS_12F,12F,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,HRAS_12F,12F,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,HRAS_12F,12F,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_12R,12R,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,HRAS_12R,12R,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12R,12R,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_12R,12R,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_12R,12R,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.01,HRAS_12R,12R,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0.001,0,0,0.006,HRAS_12R,12R,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_12R,12R,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_12R,12R,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,HRAS_12R,12R,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_12R,12R,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_12R,12R,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_12R,12R,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12R,12R,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_12R,12R,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_12R,12R,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.003,0,0,0.029,HRAS_12R,12R,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.001,0,0,0.013,HRAS_12R,12R,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.002,0,0,0.026,HRAS_12R,12R,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12R,12R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.035,HRAS_12R,12R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.034,HRAS_12R,12R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.024,HRAS_12R,12R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,HRAS_12R,12R,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,HRAS_12R,12R,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,HRAS_12R,12R,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.023,HRAS_12R,12R,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,HRAS_12R,12R,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.005,0,0,0.058,HRAS_12R,12R,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,HRAS_12R,12R,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.03,HRAS_12R,12R,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,colorectal cancer,Male,1,3694,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,cancer of unknown primary,Female,1,999,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,breast cancer,Female,3,9283,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.008,HRAS_12S,12S,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,head and neck cancer,Female,4,564,0.007,0.006,0.003,0.013,HRAS_12S,12S,NA
single,Sex,HRAS,head and neck cancer,Male,7,1179,0.006,0.006,0.003,0.011,HRAS_12S,12S,NA
single,Sex,HRAS,uterine cancer,Female,2,2248,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,1,183,0.005,0.004,0.001,0.015,HRAS_12S,12S,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,1,330,0.004,0.003,0,0.012,HRAS_12S,12S,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_12S,12S,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,HRAS_12S,12S,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,ovarian cancer,Female,1,2336,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Sex,HRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0.001,0.001,0,0.005,HRAS_12S,12S,NA
single,Sex,HRAS,bladder cancer,Male,3,1187,0.002,0.002,0.001,0.006,HRAS_12S,12S,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_12S,12S,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.01,HRAS_12S,12S,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,vaginal cancer,Female,1,78,0.015,0.011,0.001,0.051,HRAS_12S,12S,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0.006,0.003,0,0.025,HRAS_12S,12S,NA
single,Sex,HRAS,thymic tumor,Male,1,86,0.01,0.007,0,0.035,HRAS_12S,12S,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,HRAS_12S,12S,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_12S,12S,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_12S,12S,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12S,12S,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_12S,12S,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_12S,12S,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.003,0,0,0.029,HRAS_12S,12S,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.001,0,0,0.013,HRAS_12S,12S,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.002,0,0,0.026,HRAS_12S,12S,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12S,12S,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.035,HRAS_12S,12S,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.034,HRAS_12S,12S,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.024,HRAS_12S,12S,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,HRAS_12S,12S,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,HRAS_12S,12S,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,HRAS_12S,12S,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.023,HRAS_12S,12S,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,HRAS_12S,12S,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.005,0,0,0.058,HRAS_12S,12S,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,HRAS_12S,12S,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.03,HRAS_12S,12S,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0.002,HRAS_12V,12V,NA
single,Sex,HRAS,cancer of unknown primary,Male,1,986,0.001,0.001,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,breast cancer,Female,1,9283,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.008,HRAS_12V,12V,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0.002,HRAS_12V,12V,NA
single,Sex,HRAS,soft tissue sarcoma,Male,2,1338,0.001,0.001,0,0.004,HRAS_12V,12V,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,HRAS_12V,12V,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_12V,12V,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_12V,12V,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0.001,0,0,0.008,HRAS_12V,12V,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_12V,12V,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.005,HRAS_12V,12V,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.004,HRAS_12V,12V,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_12V,12V,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_12V,12V,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_12V,12V,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_12V,12V,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.008,HRAS_12V,12V,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,HRAS_12V,12V,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.042,HRAS_12V,12V,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_12V,12V,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.026,HRAS_12V,12V,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,HRAS_12V,12V,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,HRAS_12V,12V,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,HRAS_12V,12V,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,HRAS_12V,12V,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,HRAS_12V,12V,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,HRAS_12V,12V,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,HRAS_12V,12V,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.042,HRAS_12V,12V,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,HRAS_12V,12V,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,HRAS_12V,12V,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,melanoma,Male,1,1742,0.001,0,0,0.002,HRAS_13C,13C,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0.002,HRAS_13C,13C,NA
single,Sex,HRAS,head and neck cancer,Male,1,1179,0.001,0.001,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,cns cancer,Male,1,2569,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_13C,13C,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_13C,13C,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0.001,0,0,0.008,HRAS_13C,13C,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_13C,13C,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.005,HRAS_13C,13C,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.004,HRAS_13C,13C,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_13C,13C,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_13C,13C,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.005,HRAS_13C,13C,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.005,HRAS_13C,13C,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.008,HRAS_13C,13C,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,HRAS_13C,13C,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.042,HRAS_13C,13C,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_13C,13C,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.026,HRAS_13C,13C,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,HRAS_13C,13C,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,HRAS_13C,13C,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,HRAS_13C,13C,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,HRAS_13C,13C,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,HRAS_13C,13C,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,HRAS_13C,13C,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,HRAS_13C,13C,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.042,HRAS_13C,13C,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,HRAS_13C,13C,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,HRAS_13C,13C,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,melanoma,Female,3,1104,0.002,0.002,0.001,0.005,HRAS_13D,13D,NA
single,Sex,HRAS,melanoma,Male,3,1742,0.002,0.002,0.001,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,HRAS_13D,13D,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,ovarian cancer,Female,1,2336,0.001,0,0,0.002,HRAS_13D,13D,NA
single,Sex,HRAS,esophagogastric cancer,Female,1,504,0.002,0.001,0,0.007,HRAS_13D,13D,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0.002,HRAS_13D,13D,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,prostate cancer,Male,2,2436,0.001,0.001,0,0.002,HRAS_13D,13D,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0.001,0.001,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,bladder cancer,Male,2,1187,0.002,0.001,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_13D,13D,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_13D,13D,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.005,HRAS_13D,13D,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0.001,0,0,0.007,HRAS_13D,13D,NA
single,Sex,HRAS,thymic tumor,Female,1,68,0.011,0.008,0,0.043,HRAS_13D,13D,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0.005,0.003,0,0.024,HRAS_13D,13D,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,HRAS_13D,13D,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_13D,13D,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.003,HRAS_13D,13D,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.004,HRAS_13D,13D,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.018,HRAS_13D,13D,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,HRAS_13D,13D,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.005,0,0,0.059,HRAS_13D,13D,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0.001,HRAS_13D,13D,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_13D,13D,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.023,HRAS_13D,13D,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,HRAS_13D,13D,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.013,HRAS_13D,13D,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.01,HRAS_13D,13D,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.011,HRAS_13D,13D,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,HRAS_13D,13D,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,HRAS_13D,13D,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.017,HRAS_13D,13D,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.035,HRAS_13D,13D,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.07,HRAS_13D,13D,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.033,HRAS_13D,13D,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,cancer of unknown primary,Female,3,999,0.003,0.002,0,0.007,HRAS_13R,13R,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,non-small cell lung cancer,Female,3,5722,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,non-small cell lung cancer,Male,1,4406,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,breast cancer,Female,5,9283,0.001,0.001,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.01,HRAS_13R,13R,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,pancreatic cancer,Male,1,1340,0.001,0,0,0.002,HRAS_13R,13R,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,melanoma,Male,1,1742,0.001,0.001,0,0.002,HRAS_13R,13R,NA
single,Sex,HRAS,head and neck cancer,Female,2,564,0.005,0.005,0.001,0.01,HRAS_13R,13R,NA
single,Sex,HRAS,head and neck cancer,Male,8,1179,0.006,0.006,0.003,0.011,HRAS_13R,13R,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,HRAS_13R,13R,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,HRAS_13R,13R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_13R,13R,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,HRAS_13R,13R,NA
single,Sex,HRAS,soft tissue sarcoma,Female,1,1400,0.001,0.001,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,soft tissue sarcoma,Male,3,1338,0.002,0.002,0,0.004,HRAS_13R,13R,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,thyroid cancer,Female,1,537,0.002,0.002,0,0.006,HRAS_13R,13R,NA
single,Sex,HRAS,thyroid cancer,Male,1,480,0.002,0.002,0,0.007,HRAS_13R,13R,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,cns cancer,Male,1,2569,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,prostate cancer,Male,1,2436,0,0,0,0.002,HRAS_13R,13R,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.004,HRAS_13R,13R,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0.002,0,0,0.008,HRAS_13R,13R,NA
single,Sex,HRAS,bladder cancer,Male,8,1187,0.006,0.006,0.003,0.012,HRAS_13R,13R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_13R,13R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_13R,13R,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.005,HRAS_13R,13R,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0.001,0,0,0.007,HRAS_13R,13R,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,HRAS_13R,13R,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_13R,13R,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.003,HRAS_13R,13R,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0.001,0.001,0,0.006,HRAS_13R,13R,NA
single,Sex,HRAS,germ cell tumor,Male,1,710,0.001,0.001,0,0.005,HRAS_13R,13R,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.004,HRAS_13R,13R,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.004,HRAS_13R,13R,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.001,0,0,0.018,HRAS_13R,13R,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,HRAS_13R,13R,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.005,0,0,0.059,HRAS_13R,13R,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0.001,HRAS_13R,13R,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_13R,13R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.023,HRAS_13R,13R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,HRAS_13R,13R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.013,HRAS_13R,13R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.01,HRAS_13R,13R,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.011,HRAS_13R,13R,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,HRAS_13R,13R,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,HRAS_13R,13R,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.017,HRAS_13R,13R,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.035,HRAS_13R,13R,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.07,HRAS_13R,13R,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.033,HRAS_13R,13R,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,cancer of unknown primary,Female,1,999,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,non-small cell lung cancer,Female,4,5722,0.001,0.001,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,non-small cell lung cancer,Male,2,4406,0.001,0.001,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,breast cancer,Female,1,9283,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,melanoma,Male,2,1742,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,head and neck cancer,Female,2,564,0.003,0.002,0,0.008,HRAS_13V,13V,NA
single,Sex,HRAS,head and neck cancer,Male,1,1179,0.002,0.001,0,0.004,HRAS_13V,13V,NA
single,Sex,HRAS,uterine cancer,Female,1,2248,0.001,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.003,0.002,0,0.011,HRAS_13V,13V,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,2,330,0.005,0.004,0.001,0.015,HRAS_13V,13V,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_13V,13V,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,HRAS_13V,13V,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.004,HRAS_13V,13V,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.005,HRAS_13V,13V,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,bladder cancer,Female,2,393,0.004,0.003,0.001,0.011,HRAS_13V,13V,NA
single,Sex,HRAS,bladder cancer,Male,1,1187,0.002,0.001,0,0.004,HRAS_13V,13V,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,HRAS_13V,13V,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_13V,13V,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.006,HRAS_13V,13V,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.006,HRAS_13V,13V,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.005,HRAS_13V,13V,NA
single,Sex,HRAS,small cell lung cancer,Female,1,193,0.004,0.003,0,0.016,HRAS_13V,13V,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0.002,0.001,0,0.009,HRAS_13V,13V,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_13V,13V,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.003,HRAS_13V,13V,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.027,HRAS_13V,13V,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,HRAS_13V,13V,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,HRAS_13V,13V,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_13V,13V,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,HRAS_13V,13V,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,HRAS_13V,13V,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,HRAS_13V,13V,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,HRAS_13V,13V,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,HRAS_13V,13V,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,HRAS_13V,13V,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,HRAS_13V,13V,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.035,HRAS_13V,13V,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,HRAS_13V,13V,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,HRAS_13V,13V,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,non-small cell lung cancer,Male,2,4406,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,uterine cancer,Female,1,2248,0.001,0,0,0.002,HRAS_61H,61H,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_61H,61H,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,HRAS_61H,61H,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.003,HRAS_61H,61H,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_61H,61H,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_61H,61H,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_61H,61H,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_61H,61H,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_61H,61H,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,HRAS_61H,61H,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.005,HRAS_61H,61H,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_61H,61H,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_61H,61H,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.005,HRAS_61H,61H,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_61H,61H,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.004,HRAS_61H,61H,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.004,HRAS_61H,61H,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.023,HRAS_61H,61H,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.033,HRAS_61H,61H,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.04,HRAS_61H,61H,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_61H,61H,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.036,HRAS_61H,61H,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.035,HRAS_61H,61H,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.016,HRAS_61H,61H,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.013,HRAS_61H,61H,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,HRAS_61H,61H,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.012,HRAS_61H,61H,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,HRAS_61H,61H,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,HRAS_61H,61H,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.002,0,0,0.026,HRAS_61H,61H,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.047,HRAS_61H,61H,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.027,HRAS_61H,61H,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,cancer of unknown primary,Female,1,999,0.001,0.001,0,0.004,HRAS_61K,61K,NA
single,Sex,HRAS,cancer of unknown primary,Male,2,986,0.002,0.002,0,0.005,HRAS_61K,61K,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,breast cancer,Female,2,9283,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.008,HRAS_61K,61K,NA
single,Sex,HRAS,pancreatic cancer,Female,1,1153,0.001,0,0,0.003,HRAS_61K,61K,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,melanoma,Female,2,1104,0.003,0.002,0.001,0.005,HRAS_61K,61K,NA
single,Sex,HRAS,melanoma,Male,6,1742,0.003,0.003,0.001,0.006,HRAS_61K,61K,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0.001,0,0,0.005,HRAS_61K,61K,NA
single,Sex,HRAS,head and neck cancer,Male,5,1179,0.004,0.004,0.001,0.008,HRAS_61K,61K,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.003,0.002,0,0.011,HRAS_61K,61K,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,2,330,0.005,0.004,0.001,0.015,HRAS_61K,61K,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,soft tissue sarcoma,Female,1,1400,0.001,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,thyroid cancer,Female,8,537,0.013,0.013,0.006,0.024,HRAS_61K,61K,NA
single,Sex,HRAS,thyroid cancer,Male,4,480,0.011,0.01,0.004,0.019,HRAS_61K,61K,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0.001,0,0,0.003,HRAS_61K,61K,NA
single,Sex,HRAS,hepatobiliary cancer,Male,1,738,0.001,0.001,0,0.004,HRAS_61K,61K,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,prostate cancer,Male,6,2436,0.003,0.002,0.001,0.005,HRAS_61K,61K,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_61K,61K,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,bladder cancer,Female,1,393,0.003,0.003,0.001,0.008,HRAS_61K,61K,NA
single,Sex,HRAS,bladder cancer,Male,4,1187,0.003,0.003,0.001,0.007,HRAS_61K,61K,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_61K,61K,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.01,HRAS_61K,61K,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.006,HRAS_61K,61K,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.004,HRAS_61K,61K,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.004,HRAS_61K,61K,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.008,HRAS_61K,61K,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_61K,61K,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_61K,61K,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_61K,61K,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.002,HRAS_61K,61K,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.019,HRAS_61K,61K,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.024,HRAS_61K,61K,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.029,HRAS_61K,61K,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_61K,61K,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.037,HRAS_61K,61K,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.038,HRAS_61K,61K,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.018,HRAS_61K,61K,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,HRAS_61K,61K,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.002,0,0,0.019,HRAS_61K,61K,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.017,HRAS_61K,61K,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.026,HRAS_61K,61K,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.023,HRAS_61K,61K,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.038,HRAS_61K,61K,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.067,HRAS_61K,61K,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,HRAS_61K,61K,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,breast cancer,Female,0,9283,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,breast cancer,Male,0,48,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,pancreatic cancer,Male,0,1340,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,melanoma,Female,0,1104,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,melanoma,Male,0,1742,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,head and neck cancer,Female,0,564,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,head and neck cancer,Male,0,1179,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,HRAS_61L,61L,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,HRAS_61L,61L,NA
single,Sex,HRAS,soft tissue sarcoma,Female,0,1400,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,soft tissue sarcoma,Male,1,1338,0.001,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,thyroid cancer,Female,0,537,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,thyroid cancer,Male,0,480,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,prostate cancer,Male,0,2436,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.004,HRAS_61L,61L,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.005,HRAS_61L,61L,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,bladder cancer,Female,0,393,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,bladder cancer,Male,0,1187,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,HRAS_61L,61L,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,HRAS_61L,61L,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.006,HRAS_61L,61L,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0,0,0,0.003,HRAS_61L,61L,NA
single,Sex,HRAS,thymic tumor,Male,0,86,0,0,0,0.003,HRAS_61L,61L,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0,0,0,0.006,HRAS_61L,61L,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0,0,0,0.005,HRAS_61L,61L,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_61L,61L,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_61L,61L,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_61L,61L,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.003,HRAS_61L,61L,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.027,HRAS_61L,61L,NA
single,Sex,HRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,HRAS_61L,61L,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,HRAS_61L,61L,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_61L,61L,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,HRAS_61L,61L,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,HRAS_61L,61L,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,HRAS_61L,61L,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,HRAS_61L,61L,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,HRAS_61L,61L,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,HRAS_61L,61L,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,HRAS_61L,61L,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.035,HRAS_61L,61L,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,HRAS_61L,61L,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,HRAS_61L,61L,NA
single,Sex,HRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,colorectal cancer,Female,0,3026,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,colorectal cancer,Male,0,3694,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,cancer of unknown primary,Female,0,999,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,cancer of unknown primary,Male,0,986,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,non-small cell lung cancer,Female,2,5722,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,non-small cell lung cancer,Male,1,4406,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,breast cancer,Female,4,9283,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,breast cancer,Male,0,48,0.001,0,0,0.01,HRAS_61R,61R,NA
single,Sex,HRAS,pancreatic cancer,Female,0,1153,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,pancreatic cancer,Male,1,1340,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,leukemia,Female,0,635,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,leukemia,Male,0,925,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,melanoma,Female,2,1104,0.002,0.002,0,0.004,HRAS_61R,61R,NA
single,Sex,HRAS,melanoma,Male,3,1742,0.002,0.002,0.001,0.004,HRAS_61R,61R,NA
single,Sex,HRAS,head and neck cancer,Female,3,564,0.005,0.005,0.002,0.011,HRAS_61R,61R,NA
single,Sex,HRAS,head and neck cancer,Male,6,1179,0.005,0.005,0.002,0.009,HRAS_61R,61R,NA
single,Sex,HRAS,uterine cancer,Female,0,2248,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,HRAS_61R,61R,NA
single,Sex,HRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,HRAS_61R,61R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Female,0,482,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,soft tissue sarcoma,Female,1,1400,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,soft tissue sarcoma,Male,0,1338,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,ovarian cancer,Female,0,2336,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,esophagogastric cancer,Female,0,504,0.001,0,0,0.003,HRAS_61R,61R,NA
single,Sex,HRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,HRAS_61R,61R,NA
single,Sex,HRAS,thyroid cancer,Female,17,537,0.031,0.03,0.019,0.044,HRAS_61R,61R,NA
single,Sex,HRAS,thyroid cancer,Male,13,480,0.029,0.028,0.017,0.042,HRAS_61R,61R,NA
single,Sex,HRAS,cervical cancer,Female,0,365,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,kidney cancer,Female,0,420,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,kidney cancer,Male,0,1002,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,cns cancer,Female,0,1993,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,cns cancer,Male,0,2569,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,prostate cancer,Male,6,2436,0.003,0.002,0.001,0.005,HRAS_61R,61R,NA
single,Sex,HRAS,anal cancer,Female,0,102,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,anal cancer,Male,0,47,0,0,0,0.003,HRAS_61R,61R,NA
single,Sex,HRAS,neuroendocrine tumors,Female,0,166,0.002,0.001,0,0.011,HRAS_61R,61R,NA
single,Sex,HRAS,neuroendocrine tumors,Male,1,193,0.004,0.003,0,0.016,HRAS_61R,61R,NA
single,Sex,HRAS,bladder cancer,Female,3,393,0.01,0.009,0.003,0.017,HRAS_61R,61R,NA
single,Sex,HRAS,bladder cancer,Male,13,1187,0.011,0.01,0.006,0.016,HRAS_61R,61R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,small bowel cancer,Female,0,78,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,small bowel cancer,Male,0,132,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,HRAS_61R,61R,NA
single,Sex,HRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.01,HRAS_61R,61R,NA
single,Sex,HRAS,bone cancer,Female,0,237,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,bone cancer,Male,0,318,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,vaginal cancer,Female,0,78,0,0,0,0.006,HRAS_61R,61R,NA
single,Sex,HRAS,thymic tumor,Female,0,68,0.005,0.003,0,0.025,HRAS_61R,61R,NA
single,Sex,HRAS,thymic tumor,Male,1,86,0.01,0.007,0,0.036,HRAS_61R,61R,NA
single,Sex,HRAS,ampullary cancer,Female,0,41,0.001,0,0,0.008,HRAS_61R,61R,NA
single,Sex,HRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,HRAS_61R,61R,NA
single,Sex,HRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,mature t and nk neoplasms,Male,0,123,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,mesothelioma,Female,0,145,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,mesothelioma,Male,0,352,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,germ cell tumor,Female,0,175,0,0,0,0.001,HRAS_61R,61R,NA
single,Sex,HRAS,germ cell tumor,Male,0,710,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,nerve sheath tumor,Female,0,79,0,0,0,0.003,HRAS_61R,61R,NA
single,Sex,HRAS,nerve sheath tumor,Male,0,72,0,0,0,0.002,HRAS_61R,61R,NA
single,Sex,HRAS,penile cancer,Male,0,25,0.002,0,0,0.019,HRAS_61R,61R,NA
single,Sex,HRAS,pheochromocytoma,Male,1,17,0.067,0.05,0.003,0.221,HRAS_61R,61R,NA
single,Sex,HRAS,pineal tumor,Male,0,12,0.003,0,0,0.029,HRAS_61R,61R,NA
single,Sex,HRAS,b cell lymphoma,Female,0,395,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,b cell lymphoma,Male,0,566,0,0,0,0,HRAS_61R,61R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.037,HRAS_61R,61R,NA
single,Sex,HRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.038,HRAS_61R,61R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.018,HRAS_61R,61R,NA
single,Sex,HRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,HRAS_61R,61R,NA
single,Sex,HRAS,retinoblastoma,Female,0,23,0.002,0,0,0.019,HRAS_61R,61R,NA
single,Sex,HRAS,retinoblastoma,Male,0,28,0.001,0,0,0.017,HRAS_61R,61R,NA
single,Sex,HRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.026,HRAS_61R,61R,NA
single,Sex,HRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.023,HRAS_61R,61R,NA
single,Sex,HRAS,lung cancer,Male,0,16,0.003,0,0,0.038,HRAS_61R,61R,NA
single,Sex,HRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.067,HRAS_61R,61R,NA
single,Sex,HRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,HRAS_61R,61R,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,colorectal cancer,Female,0,3026,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,colorectal cancer,Male,5,3694,0.001,0.001,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,non-small cell lung cancer,Male,1,4406,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,leukemia,Female,6,637,0.009,0.009,0.004,0.016,NRAS_12A,12A,NA
single,Sex,NRAS,leukemia,Male,8,930,0.009,0.009,0.005,0.015,NRAS_12A,12A,NA
single,Sex,NRAS,melanoma,Female,2,1104,0.002,0.002,0,0.004,NRAS_12A,12A,NA
single,Sex,NRAS,melanoma,Male,3,1742,0.002,0.002,0.001,0.004,NRAS_12A,12A,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,uterine cancer,Female,0,2253,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,1,483,0.003,0.003,0,0.008,NRAS_12A,12A,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,3,724,0.004,0.003,0.001,0.009,NRAS_12A,12A,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.002,NRAS_12A,12A,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.002,NRAS_12A,12A,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0.001,0,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_12A,12A,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12A,12A,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.005,NRAS_12A,12A,NA
single,Sex,NRAS,anal cancer,Male,0,47,0.001,0,0,0.006,NRAS_12A,12A,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0.005,0.003,0,0.021,NRAS_12A,12A,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,2,142,0.012,0.01,0.002,0.034,NRAS_12A,12A,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.006,NRAS_12A,12A,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.013,NRAS_12A,12A,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.005,NRAS_12A,12A,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.003,NRAS_12A,12A,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.006,NRAS_12A,12A,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.005,NRAS_12A,12A,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12A,12A,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.001,0.001,0,0.006,NRAS_12A,12A,NA
single,Sex,NRAS,germ cell tumor,Male,1,711,0.001,0.001,0,0.005,NRAS_12A,12A,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,NRAS_12A,12A,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,NRAS_12A,12A,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.003,0,0,0.029,NRAS_12A,12A,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.041,NRAS_12A,12A,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.005,0,0,0.057,NRAS_12A,12A,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,b cell lymphoma,Male,0,567,0,0,0,0,NRAS_12A,12A,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.001,0,0,0.016,NRAS_12A,12A,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.001,0,0,0.016,NRAS_12A,12A,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.025,NRAS_12A,12A,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.019,NRAS_12A,12A,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.008,NRAS_12A,12A,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.008,NRAS_12A,12A,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.016,NRAS_12A,12A,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.014,NRAS_12A,12A,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.001,0,0,0.015,NRAS_12A,12A,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.055,NRAS_12A,12A,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.038,NRAS_12A,12A,NA
single,Sex,NRAS,appendiceal cancer,Female,1,174,0.005,0.003,0,0.018,NRAS_12C,12C,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0.002,0.001,0,0.011,NRAS_12C,12C,NA
single,Sex,NRAS,colorectal cancer,Female,7,3026,0.002,0.002,0.001,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,colorectal cancer,Male,9,3694,0.002,0.002,0.001,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,cancer of unknown primary,Female,1,1000,0.001,0.001,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,cancer of unknown primary,Male,1,988,0.001,0.001,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,non-small cell lung cancer,Male,2,4406,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,pancreatic cancer,Male,1,1340,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,leukemia,Female,4,637,0.006,0.005,0.002,0.011,NRAS_12C,12C,NA
single,Sex,NRAS,leukemia,Male,4,930,0.005,0.005,0.002,0.009,NRAS_12C,12C,NA
single,Sex,NRAS,melanoma,Female,7,1104,0.005,0.005,0.002,0.01,NRAS_12C,12C,NA
single,Sex,NRAS,melanoma,Male,5,1742,0.004,0.004,0.001,0.007,NRAS_12C,12C,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,head and neck cancer,Male,1,1179,0.001,0.001,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,uterine cancer,Female,5,2253,0.002,0.002,0.001,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,hepatobiliary cancer,Female,1,636,0.002,0.001,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,hepatobiliary cancer,Male,1,738,0.002,0.001,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,cns cancer,Female,1,1994,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,cns cancer,Male,1,2569,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,bladder cancer,Female,1,393,0.002,0.001,0,0.008,NRAS_12C,12C,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0.003,0.001,0,0.015,NRAS_12C,12C,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.006,0.004,0,0.022,NRAS_12C,12C,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.004,NRAS_12C,12C,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.005,NRAS_12C,12C,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0.001,0,0,0.009,NRAS_12C,12C,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0.001,0,0,0.007,NRAS_12C,12C,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12C,12C,NA
single,Sex,NRAS,germ cell tumor,Female,1,175,0.004,0.003,0,0.018,NRAS_12C,12C,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.002,NRAS_12C,12C,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.011,NRAS_12C,12C,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.024,NRAS_12C,12C,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.051,NRAS_12C,12C,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,b cell lymphoma,Male,0,567,0,0,0,0,NRAS_12C,12C,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,NRAS_12C,12C,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.027,NRAS_12C,12C,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.022,NRAS_12C,12C,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.015,NRAS_12C,12C,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0,0,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0,0,0,0.003,NRAS_12C,12C,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.017,NRAS_12C,12C,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.015,NRAS_12C,12C,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.002,0,0,0.03,NRAS_12C,12C,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.005,0,0,0.061,NRAS_12C,12C,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.037,NRAS_12C,12C,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,colorectal cancer,Female,27,3026,0.008,0.008,0.006,0.012,NRAS_12D,12D,NA
single,Sex,NRAS,colorectal cancer,Male,26,3694,0.008,0.008,0.005,0.01,NRAS_12D,12D,NA
single,Sex,NRAS,cancer of unknown primary,Female,2,1000,0.002,0.002,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,cancer of unknown primary,Male,1,988,0.001,0.001,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,non-small cell lung cancer,Female,5,5722,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,non-small cell lung cancer,Male,3,4406,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,soft tissue sarcoma,Female,1,1413,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,soft tissue sarcoma,Male,1,1360,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,pancreatic cancer,Female,1,1153,0.001,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,leukemia,Female,32,637,0.048,0.047,0.035,0.064,NRAS_12D,12D,NA
single,Sex,NRAS,leukemia,Male,39,930,0.044,0.044,0.032,0.056,NRAS_12D,12D,NA
single,Sex,NRAS,melanoma,Female,6,1104,0.006,0.006,0.003,0.01,NRAS_12D,12D,NA
single,Sex,NRAS,melanoma,Male,11,1742,0.006,0.006,0.003,0.01,NRAS_12D,12D,NA
single,Sex,NRAS,head and neck cancer,Female,1,564,0.002,0.002,0,0.005,NRAS_12D,12D,NA
single,Sex,NRAS,head and neck cancer,Male,2,1179,0.002,0.002,0,0.005,NRAS_12D,12D,NA
single,Sex,NRAS,uterine cancer,Female,8,2253,0.004,0.003,0.002,0.006,NRAS_12D,12D,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0.002,0.001,0,0.008,NRAS_12D,12D,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,1,330,0.003,0.002,0,0.01,NRAS_12D,12D,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,8,483,0.017,0.016,0.009,0.027,NRAS_12D,12D,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,12,724,0.017,0.016,0.01,0.026,NRAS_12D,12D,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,NRAS_12D,12D,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,NRAS_12D,12D,NA
single,Sex,NRAS,ovarian cancer,Female,2,2336,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,hepatobiliary cancer,Female,1,636,0.003,0.002,0,0.007,NRAS_12D,12D,NA
single,Sex,NRAS,hepatobiliary cancer,Male,3,738,0.003,0.003,0.001,0.008,NRAS_12D,12D,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,cns cancer,Male,1,2569,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12D,12D,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,neuroendocrine tumors,Female,1,166,0.005,0.003,0,0.018,NRAS_12D,12D,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0.002,0.001,0,0.011,NRAS_12D,12D,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0.001,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,bladder cancer,Male,1,1187,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,3,106,0.037,0.035,0.012,0.069,NRAS_12D,12D,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,7,142,0.044,0.042,0.02,0.08,NRAS_12D,12D,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_12D,12D,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,NRAS_12D,12D,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.011,NRAS_12D,12D,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.003,NRAS_12D,12D,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12D,12D,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.002,0.001,0,0.008,NRAS_12D,12D,NA
single,Sex,NRAS,germ cell tumor,Male,2,711,0.003,0.002,0,0.007,NRAS_12D,12D,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.014,NRAS_12D,12D,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,NRAS_12D,12D,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,NRAS_12D,12D,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0.001,0,0.004,NRAS_12D,12D,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.001,0,0.006,NRAS_12D,12D,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,NRAS_12D,12D,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,NRAS_12D,12D,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,1,12,0.059,0.038,0.002,0.237,NRAS_12D,12D,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.016,0.007,0,0.079,NRAS_12D,12D,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,NRAS_12D,12D,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,NRAS_12D,12D,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,NRAS_12D,12D,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,NRAS_12D,12D,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.037,NRAS_12D,12D,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,2,11,0.188,0.169,0.029,0.447,NRAS_12D,12D,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,NRAS_12D,12D,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,colorectal cancer,Female,0,3026,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,colorectal cancer,Male,0,3694,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,leukemia,Female,0,637,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,leukemia,Male,0,930,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,melanoma,Female,0,1104,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,melanoma,Male,0,1742,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,uterine cancer,Female,0,2253,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,NRAS_12F,12F,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,NRAS_12F,12F,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_12F,12F,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12F,12F,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_12F,12F,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_12F,12F,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.002,NRAS_12F,12F,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_12F,12F,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,NRAS_12F,12F,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.011,NRAS_12F,12F,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.003,NRAS_12F,12F,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.004,NRAS_12F,12F,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.004,NRAS_12F,12F,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.004,NRAS_12F,12F,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.003,NRAS_12F,12F,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12F,12F,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,NRAS_12F,12F,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,NRAS_12F,12F,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.014,NRAS_12F,12F,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,NRAS_12F,12F,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,NRAS_12F,12F,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,b cell lymphoma,Male,0,567,0,0,0,0,NRAS_12F,12F,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,NRAS_12F,12F,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,NRAS_12F,12F,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,NRAS_12F,12F,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,NRAS_12F,12F,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,NRAS_12F,12F,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,NRAS_12F,12F,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,NRAS_12F,12F,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,NRAS_12F,12F,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.037,NRAS_12F,12F,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,NRAS_12F,12F,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,NRAS_12F,12F,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,colorectal cancer,Female,0,3026,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,colorectal cancer,Male,0,3694,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,leukemia,Female,1,637,0.002,0.002,0,0.005,NRAS_12R,12R,NA
single,Sex,NRAS,leukemia,Male,2,930,0.002,0.002,0,0.005,NRAS_12R,12R,NA
single,Sex,NRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,melanoma,Male,2,1742,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,head and neck cancer,Female,1,564,0.001,0.001,0,0.006,NRAS_12R,12R,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,uterine cancer,Female,1,2253,0.001,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,2,483,0.004,0.004,0.001,0.01,NRAS_12R,12R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,3,724,0.004,0.004,0.001,0.009,NRAS_12R,12R,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.005,NRAS_12R,12R,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.006,NRAS_12R,12R,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_12R,12R,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,NRAS_12R,12R,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.011,NRAS_12R,12R,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.003,NRAS_12R,12R,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12R,12R,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0,0,0,0,NRAS_12R,12R,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.014,NRAS_12R,12R,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.034,NRAS_12R,12R,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.049,NRAS_12R,12R,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0.001,0,0.004,NRAS_12R,12R,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.001,0,0.006,NRAS_12R,12R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,NRAS_12R,12R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.032,NRAS_12R,12R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.003,0,0,0.031,NRAS_12R,12R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.023,NRAS_12R,12R,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.014,NRAS_12R,12R,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.014,NRAS_12R,12R,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.021,NRAS_12R,12R,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.018,NRAS_12R,12R,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.037,NRAS_12R,12R,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.004,0,0,0.051,NRAS_12R,12R,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,NRAS_12R,12R,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,colorectal cancer,Female,0,3026,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,colorectal cancer,Male,1,3694,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,cancer of unknown primary,Male,1,988,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,non-small cell lung cancer,Female,2,5722,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,breast cancer,Female,1,9283,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,breast cancer,Male,0,48,0.001,0,0,0.006,NRAS_12S,12S,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,leukemia,Female,2,637,0.004,0.004,0.001,0.008,NRAS_12S,12S,NA
single,Sex,NRAS,leukemia,Male,4,930,0.004,0.004,0.001,0.008,NRAS_12S,12S,NA
single,Sex,NRAS,melanoma,Female,2,1104,0.002,0.002,0.001,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,melanoma,Male,4,1742,0.002,0.002,0.001,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,uterine cancer,Female,2,2253,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,2,483,0.006,0.006,0.001,0.012,NRAS_12S,12S,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,6,724,0.007,0.007,0.003,0.014,NRAS_12S,12S,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0.001,0,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0.001,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,hepatobiliary cancer,Male,2,738,0.002,0.002,0,0.007,NRAS_12S,12S,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,cns cancer,Male,1,2569,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_12S,12S,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.015,0.014,0.002,0.037,NRAS_12S,12S,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,3,142,0.018,0.017,0.005,0.042,NRAS_12S,12S,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.009,NRAS_12S,12S,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_12S,12S,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.002,NRAS_12S,12S,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12S,12S,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.001,0.001,0,0.006,NRAS_12S,12S,NA
single,Sex,NRAS,germ cell tumor,Male,1,711,0.001,0.001,0,0.005,NRAS_12S,12S,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.004,NRAS_12S,12S,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.002,0,0,0.022,NRAS_12S,12S,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.023,NRAS_12S,12S,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.002,0,0,0.029,NRAS_12S,12S,NA
single,Sex,NRAS,b cell lymphoma,Female,1,395,0.003,0.002,0,0.008,NRAS_12S,12S,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.002,0,0.006,NRAS_12S,12S,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.032,NRAS_12S,12S,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.03,NRAS_12S,12S,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.023,0.013,0,0.103,NRAS_12S,12S,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,1,28,0.032,0.023,0.001,0.11,NRAS_12S,12S,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,NRAS_12S,12S,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.01,NRAS_12S,12S,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.022,NRAS_12S,12S,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.019,NRAS_12S,12S,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.043,NRAS_12S,12S,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,NRAS_12S,12S,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.039,NRAS_12S,12S,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,colorectal cancer,Female,3,3026,0.001,0.001,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,colorectal cancer,Male,4,3694,0.001,0.001,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,cancer of unknown primary,Female,1,1000,0.002,0.001,0,0.004,NRAS_12V,12V,NA
single,Sex,NRAS,cancer of unknown primary,Male,2,988,0.002,0.002,0,0.005,NRAS_12V,12V,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,non-small cell lung cancer,Male,3,4406,0.001,0.001,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,soft tissue sarcoma,Female,1,1413,0.001,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,leukemia,Female,5,637,0.006,0.006,0.002,0.013,NRAS_12V,12V,NA
single,Sex,NRAS,leukemia,Male,3,930,0.005,0.004,0.001,0.009,NRAS_12V,12V,NA
single,Sex,NRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,melanoma,Male,2,1742,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,uterine cancer,Female,1,2253,0.001,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0.001,0,0.005,NRAS_12V,12V,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,3,724,0.004,0.003,0.001,0.009,NRAS_12V,12V,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0.001,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,hepatobiliary cancer,Male,1,738,0.001,0.001,0,0.004,NRAS_12V,12V,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_12V,12V,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0,NRAS_12V,12V,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0.001,0,0,0.008,NRAS_12V,12V,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.005,NRAS_12V,12V,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.005,NRAS_12V,12V,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.005,NRAS_12V,12V,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.004,NRAS_12V,12V,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_12V,12V,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.002,0.001,0,0.008,NRAS_12V,12V,NA
single,Sex,NRAS,germ cell tumor,Male,2,711,0.003,0.002,0,0.007,NRAS_12V,12V,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.002,NRAS_12V,12V,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.008,NRAS_12V,12V,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,NRAS_12V,12V,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.003,0,0,0.042,NRAS_12V,12V,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0,0,0.004,NRAS_12V,12V,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.001,0,0.006,NRAS_12V,12V,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.034,0.018,0,0.151,NRAS_12V,12V,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,1,11,0.069,0.048,0.003,0.248,NRAS_12V,12V,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,NRAS_12V,12V,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,NRAS_12V,12V,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,NRAS_12V,12V,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,NRAS_12V,12V,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,NRAS_12V,12V,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,NRAS_12V,12V,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.042,NRAS_12V,12V,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,1,11,0.101,0.078,0.005,0.324,NRAS_12V,12V,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,NRAS_12V,12V,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,colorectal cancer,Female,2,3026,0.001,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,colorectal cancer,Male,1,3694,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,leukemia,Female,0,637,0.001,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,leukemia,Male,1,930,0.001,0.001,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,melanoma,Female,0,1104,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,melanoma,Male,4,1742,0.002,0.002,0.001,0.005,NRAS_13C,13C,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,uterine cancer,Female,0,2253,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,2,483,0.004,0.004,0.001,0.01,NRAS_13C,13C,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,3,724,0.004,0.004,0.001,0.009,NRAS_13C,13C,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_13C,13C,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0.001,0,0,0.008,NRAS_13C,13C,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.005,NRAS_13C,13C,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.005,NRAS_13C,13C,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.005,NRAS_13C,13C,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.004,NRAS_13C,13C,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0,0,0,0.001,NRAS_13C,13C,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0,0,0,0,NRAS_13C,13C,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.002,NRAS_13C,13C,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.008,NRAS_13C,13C,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.029,NRAS_13C,13C,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.003,0,0,0.042,NRAS_13C,13C,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0,0,0.004,NRAS_13C,13C,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.001,0,0.006,NRAS_13C,13C,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.026,NRAS_13C,13C,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,NRAS_13C,13C,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.02,NRAS_13C,13C,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,NRAS_13C,13C,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.016,NRAS_13C,13C,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,NRAS_13C,13C,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.018,NRAS_13C,13C,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.016,NRAS_13C,13C,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.042,NRAS_13C,13C,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.003,0,0,0.041,NRAS_13C,13C,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.023,NRAS_13C,13C,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,colorectal cancer,Female,6,3026,0.002,0.002,0.001,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,colorectal cancer,Male,6,3694,0.002,0.002,0.001,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,breast cancer,Female,1,9283,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,breast cancer,Male,0,48,0.001,0,0,0.008,NRAS_13D,13D,NA
single,Sex,NRAS,soft tissue sarcoma,Female,1,1413,0.001,0.001,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,soft tissue sarcoma,Male,2,1360,0.001,0.001,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,leukemia,Female,14,637,0.021,0.021,0.013,0.032,NRAS_13D,13D,NA
single,Sex,NRAS,leukemia,Male,18,930,0.02,0.02,0.013,0.029,NRAS_13D,13D,NA
single,Sex,NRAS,melanoma,Female,0,1104,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,melanoma,Male,8,1742,0.004,0.004,0.002,0.008,NRAS_13D,13D,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,uterine cancer,Female,1,2253,0.001,0,0,0.002,NRAS_13D,13D,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,5,483,0.009,0.008,0.004,0.018,NRAS_13D,13D,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,4,724,0.007,0.007,0.003,0.013,NRAS_13D,13D,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,NRAS_13D,13D,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.005,NRAS_13D,13D,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,esophagogastric cancer,Female,1,504,0.002,0.001,0,0.007,NRAS_13D,13D,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0.002,NRAS_13D,13D,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,cns cancer,Male,1,2569,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.004,NRAS_13D,13D,NA
single,Sex,NRAS,neuroendocrine tumors,Female,1,166,0.005,0.003,0,0.018,NRAS_13D,13D,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0.002,0.001,0,0.01,NRAS_13D,13D,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,3,106,0.026,0.024,0.008,0.055,NRAS_13D,13D,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,3,142,0.024,0.023,0.008,0.049,NRAS_13D,13D,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.005,NRAS_13D,13D,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_13D,13D,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0.001,0,0,0.007,NRAS_13D,13D,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.003,NRAS_13D,13D,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,NRAS_13D,13D,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,NRAS_13D,13D,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_13D,13D,NA
single,Sex,NRAS,germ cell tumor,Female,1,175,0.004,0.003,0,0.018,NRAS_13D,13D,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0.001,0,0,0.004,NRAS_13D,13D,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.005,NRAS_13D,13D,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.005,NRAS_13D,13D,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.018,NRAS_13D,13D,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,NRAS_13D,13D,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.005,0,0,0.059,NRAS_13D,13D,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0.001,0,0.005,NRAS_13D,13D,NA
single,Sex,NRAS,b cell lymphoma,Male,2,567,0.003,0.003,0,0.009,NRAS_13D,13D,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.023,NRAS_13D,13D,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.025,NRAS_13D,13D,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.013,NRAS_13D,13D,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.01,NRAS_13D,13D,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.011,NRAS_13D,13D,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,NRAS_13D,13D,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,NRAS_13D,13D,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.017,NRAS_13D,13D,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.035,NRAS_13D,13D,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,1,11,0.101,0.078,0.004,0.325,NRAS_13D,13D,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.033,NRAS_13D,13D,NA
single,Sex,NRAS,appendiceal cancer,Female,1,174,0.005,0.003,0,0.017,NRAS_13R,13R,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0.002,0.001,0,0.011,NRAS_13R,13R,NA
single,Sex,NRAS,colorectal cancer,Female,12,3026,0.003,0.003,0.002,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,colorectal cancer,Male,7,3694,0.002,0.002,0.001,0.004,NRAS_13R,13R,NA
single,Sex,NRAS,cancer of unknown primary,Female,2,1000,0.002,0.002,0.001,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,cancer of unknown primary,Male,3,988,0.003,0.003,0.001,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,non-small cell lung cancer,Female,0,5722,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,non-small cell lung cancer,Male,2,4406,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,leukemia,Female,1,637,0.003,0.003,0,0.008,NRAS_13R,13R,NA
single,Sex,NRAS,leukemia,Male,6,930,0.006,0.005,0.002,0.011,NRAS_13R,13R,NA
single,Sex,NRAS,melanoma,Female,6,1104,0.006,0.006,0.003,0.011,NRAS_13R,13R,NA
single,Sex,NRAS,melanoma,Male,14,1742,0.008,0.007,0.004,0.012,NRAS_13R,13R,NA
single,Sex,NRAS,head and neck cancer,Female,2,564,0.003,0.002,0,0.009,NRAS_13R,13R,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0.002,NRAS_13R,13R,NA
single,Sex,NRAS,uterine cancer,Female,0,2253,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,1,483,0.002,0.001,0,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0.001,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,1,80,0.011,0.008,0,0.038,NRAS_13R,13R,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0.007,0.004,0,0.03,NRAS_13R,13R,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,thyroid cancer,Female,1,537,0.002,0.002,0,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,thyroid cancer,Male,1,480,0.002,0.002,0,0.007,NRAS_13R,13R,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,hepatobiliary cancer,Female,1,636,0.002,0.002,0,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,hepatobiliary cancer,Male,2,738,0.003,0.002,0,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.004,NRAS_13R,13R,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Sex,NRAS,bladder cancer,Male,2,1187,0.002,0.001,0,0.004,NRAS_13R,13R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0.004,0.002,0,0.016,NRAS_13R,13R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.006,0.004,0,0.022,NRAS_13R,13R,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,sex cord stromal tumor,Female,1,97,0.011,0.008,0,0.038,NRAS_13R,13R,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.013,0.006,0,0.069,NRAS_13R,13R,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_13R,13R,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0.001,0,0,0.007,NRAS_13R,13R,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.003,NRAS_13R,13R,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0.001,0,0,0.007,NRAS_13R,13R,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,NRAS_13R,13R,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_13R,13R,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.002,0.001,0,0.007,NRAS_13R,13R,NA
single,Sex,NRAS,germ cell tumor,Male,2,711,0.003,0.002,0,0.007,NRAS_13R,13R,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.005,NRAS_13R,13R,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.005,NRAS_13R,13R,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.018,NRAS_13R,13R,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,NRAS_13R,13R,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.005,0,0,0.059,NRAS_13R,13R,NA
single,Sex,NRAS,b cell lymphoma,Female,1,395,0.002,0.001,0,0.008,NRAS_13R,13R,NA
single,Sex,NRAS,b cell lymphoma,Male,0,567,0.001,0,0,0.004,NRAS_13R,13R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.033,0.018,0,0.145,NRAS_13R,13R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,1,11,0.069,0.048,0.003,0.254,NRAS_13R,13R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.025,0.015,0,0.105,NRAS_13R,13R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,1,28,0.032,0.024,0.002,0.111,NRAS_13R,13R,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.011,NRAS_13R,13R,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,NRAS_13R,13R,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.019,NRAS_13R,13R,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.017,NRAS_13R,13R,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.035,NRAS_13R,13R,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.07,NRAS_13R,13R,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.033,NRAS_13R,13R,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,colorectal cancer,Female,0,3026,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,colorectal cancer,Male,0,3694,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,cancer of unknown primary,Male,0,988,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,non-small cell lung cancer,Male,0,4406,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,soft tissue sarcoma,Female,0,1413,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,soft tissue sarcoma,Male,0,1360,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,pancreatic cancer,Female,1,1153,0.001,0,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,leukemia,Female,3,637,0.004,0.003,0.001,0.009,NRAS_13V,13V,NA
single,Sex,NRAS,leukemia,Male,2,930,0.003,0.003,0.001,0.007,NRAS_13V,13V,NA
single,Sex,NRAS,melanoma,Female,1,1104,0.001,0.001,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,melanoma,Male,3,1742,0.002,0.001,0,0.004,NRAS_13V,13V,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,uterine cancer,Female,0,2253,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,1,483,0.004,0.003,0,0.009,NRAS_13V,13V,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,4,724,0.005,0.004,0.002,0.01,NRAS_13V,13V,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,NRAS_13V,13V,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,NRAS_13V,13V,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_13V,13V,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.004,NRAS_13V,13V,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.005,NRAS_13V,13V,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0.004,0.002,0,0.017,NRAS_13V,13V,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.006,0.004,0,0.021,NRAS_13V,13V,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_13V,13V,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_13V,13V,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,NRAS_13V,13V,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.006,NRAS_13V,13V,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.002,NRAS_13V,13V,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.006,NRAS_13V,13V,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.005,NRAS_13V,13V,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_13V,13V,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,NRAS_13V,13V,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.002,0,0,0.027,NRAS_13V,13V,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,NRAS_13V,13V,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,NRAS_13V,13V,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,b cell lymphoma,Male,0,567,0,0,0,0,NRAS_13V,13V,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,NRAS_13V,13V,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,NRAS_13V,13V,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,NRAS_13V,13V,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,NRAS_13V,13V,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,NRAS_13V,13V,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,NRAS_13V,13V,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,NRAS_13V,13V,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.035,NRAS_13V,13V,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,NRAS_13V,13V,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,NRAS_13V,13V,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,colorectal cancer,Female,6,3026,0.002,0.002,0.001,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,colorectal cancer,Male,11,3694,0.003,0.003,0.002,0.005,NRAS_61H,61H,NA
single,Sex,NRAS,cancer of unknown primary,Female,1,1000,0.001,0.001,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,cancer of unknown primary,Male,2,988,0.002,0.002,0,0.005,NRAS_61H,61H,NA
single,Sex,NRAS,non-small cell lung cancer,Female,1,5722,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,non-small cell lung cancer,Male,3,4406,0.001,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,soft tissue sarcoma,Female,1,1413,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,soft tissue sarcoma,Male,2,1360,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,leukemia,Female,4,637,0.005,0.005,0.002,0.011,NRAS_61H,61H,NA
single,Sex,NRAS,leukemia,Male,3,930,0.004,0.004,0.001,0.008,NRAS_61H,61H,NA
single,Sex,NRAS,melanoma,Female,10,1104,0.009,0.009,0.005,0.014,NRAS_61H,61H,NA
single,Sex,NRAS,melanoma,Male,17,1742,0.01,0.01,0.006,0.014,NRAS_61H,61H,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0.001,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,head and neck cancer,Male,1,1179,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,uterine cancer,Female,4,2253,0.002,0.002,0.001,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,1,724,0.001,0.001,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,ovarian cancer,Female,0,2336,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,esophagogastric cancer,Male,0,1297,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,NRAS_61H,61H,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0.004,0.002,0,0.017,NRAS_61H,61H,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,1,124,0.007,0.005,0,0.024,NRAS_61H,61H,NA
single,Sex,NRAS,cns cancer,Female,0,1994,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,cns cancer,Male,0,2569,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,prostate cancer,Male,2,2436,0.001,0.001,0,0.002,NRAS_61H,61H,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.009,0.008,0.001,0.028,NRAS_61H,61H,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.009,0.007,0.001,0.025,NRAS_61H,61H,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_61H,61H,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.008,NRAS_61H,61H,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_61H,61H,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.006,NRAS_61H,61H,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.004,NRAS_61H,61H,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0.001,NRAS_61H,61H,NA
single,Sex,NRAS,germ cell tumor,Female,1,175,0.005,0.004,0.001,0.015,NRAS_61H,61H,NA
single,Sex,NRAS,germ cell tumor,Male,2,711,0.003,0.003,0.001,0.008,NRAS_61H,61H,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,NRAS_61H,61H,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.001,0,0,0.017,NRAS_61H,61H,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.003,0,0,0.035,NRAS_61H,61H,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.005,0,0,0.055,NRAS_61H,61H,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0.001,0,0.005,NRAS_61H,61H,NA
single,Sex,NRAS,b cell lymphoma,Male,2,567,0.003,0.003,0,0.009,NRAS_61H,61H,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,1,12,0.063,0.044,0.003,0.225,NRAS_61H,61H,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.037,0.022,0,0.159,NRAS_61H,61H,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.023,NRAS_61H,61H,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.002,0,0,0.018,NRAS_61H,61H,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.015,NRAS_61H,61H,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.015,NRAS_61H,61H,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.015,NRAS_61H,61H,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.012,NRAS_61H,61H,NA
single,Sex,NRAS,lung cancer,Male,1,16,0.07,0.054,0.003,0.23,NRAS_61H,61H,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.005,0,0,0.063,NRAS_61H,61H,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.019,NRAS_61H,61H,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,colorectal cancer,Female,32,3026,0.01,0.01,0.007,0.014,NRAS_61K,61K,NA
single,Sex,NRAS,colorectal cancer,Male,33,3694,0.009,0.009,0.007,0.012,NRAS_61K,61K,NA
single,Sex,NRAS,cancer of unknown primary,Female,4,1000,0.004,0.004,0.001,0.008,NRAS_61K,61K,NA
single,Sex,NRAS,cancer of unknown primary,Male,3,988,0.004,0.003,0.001,0.007,NRAS_61K,61K,NA
single,Sex,NRAS,non-small cell lung cancer,Female,6,5722,0.001,0.001,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,non-small cell lung cancer,Male,2,4406,0.001,0.001,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,soft tissue sarcoma,Female,6,1413,0.005,0.005,0.002,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,soft tissue sarcoma,Male,9,1360,0.006,0.006,0.003,0.01,NRAS_61K,61K,NA
single,Sex,NRAS,pancreatic cancer,Female,2,1153,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,leukemia,Female,5,637,0.009,0.008,0.004,0.015,NRAS_61K,61K,NA
single,Sex,NRAS,leukemia,Male,9,930,0.009,0.009,0.005,0.015,NRAS_61K,61K,NA
single,Sex,NRAS,melanoma,Female,74,1104,0.068,0.068,0.056,0.082,NRAS_61K,61K,NA
single,Sex,NRAS,melanoma,Male,125,1742,0.071,0.071,0.06,0.082,NRAS_61K,61K,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0.001,0,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,head and neck cancer,Male,3,1179,0.002,0.002,0,0.006,NRAS_61K,61K,NA
single,Sex,NRAS,uterine cancer,Female,6,2253,0.003,0.003,0.001,0.005,NRAS_61K,61K,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,ovarian cancer,Female,5,2336,0.002,0.002,0.001,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0.001,0,0,0.003,NRAS_61K,61K,NA
single,Sex,NRAS,esophagogastric cancer,Male,2,1297,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,thyroid cancer,Female,16,537,0.029,0.029,0.019,0.043,NRAS_61K,61K,NA
single,Sex,NRAS,thyroid cancer,Male,13,480,0.028,0.028,0.017,0.041,NRAS_61K,61K,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,hepatobiliary cancer,Female,4,636,0.006,0.005,0.002,0.012,NRAS_61K,61K,NA
single,Sex,NRAS,hepatobiliary cancer,Male,3,738,0.005,0.005,0.002,0.01,NRAS_61K,61K,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,cns cancer,Female,3,1994,0.002,0.002,0.001,0.003,NRAS_61K,61K,NA
single,Sex,NRAS,cns cancer,Male,5,2569,0.002,0.002,0.001,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,prostate cancer,Male,1,2436,0,0,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.004,NRAS_61K,61K,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.005,NRAS_61K,61K,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_61K,61K,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0.001,0.001,0,0.005,NRAS_61K,61K,NA
single,Sex,NRAS,bladder cancer,Male,3,1187,0.002,0.002,0.001,0.006,NRAS_61K,61K,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,2,106,0.015,0.013,0.003,0.04,NRAS_61K,61K,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.011,0.01,0.001,0.029,NRAS_61K,61K,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_61K,61K,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,NRAS_61K,61K,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,NRAS_61K,61K,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.006,NRAS_61K,61K,NA
single,Sex,NRAS,thymic tumor,Female,1,70,0.011,0.008,0,0.042,NRAS_61K,61K,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0.005,0.002,0,0.023,NRAS_61K,61K,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.006,NRAS_61K,61K,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.005,NRAS_61K,61K,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0.002,0.001,0,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,small cell lung cancer,Male,1,205,0.004,0.003,0,0.015,NRAS_61K,61K,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0,NRAS_61K,61K,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.002,0.002,0,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,germ cell tumor,Male,3,711,0.004,0.004,0.001,0.01,NRAS_61K,61K,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,NRAS_61K,61K,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,NRAS_61K,61K,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.002,0,0,0.027,NRAS_61K,61K,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,NRAS_61K,61K,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,NRAS_61K,61K,NA
single,Sex,NRAS,b cell lymphoma,Female,2,395,0.004,0.003,0.001,0.011,NRAS_61K,61K,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.003,0.003,0,0.008,NRAS_61K,61K,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,NRAS_61K,61K,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,NRAS_61K,61K,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,NRAS_61K,61K,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,NRAS_61K,61K,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,NRAS_61K,61K,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.035,NRAS_61K,61K,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,NRAS_61K,61K,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,NRAS_61K,61K,NA
single,Sex,NRAS,appendiceal cancer,Female,0,174,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,appendiceal cancer,Male,0,167,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,colorectal cancer,Female,12,3026,0.004,0.003,0.002,0.006,NRAS_61L,61L,NA
single,Sex,NRAS,colorectal cancer,Male,10,3694,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,cancer of unknown primary,Female,0,1000,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,cancer of unknown primary,Male,1,988,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,non-small cell lung cancer,Female,18,5722,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,non-small cell lung cancer,Male,14,4406,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,soft tissue sarcoma,Female,1,1413,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,soft tissue sarcoma,Male,3,1360,0.002,0.002,0,0.004,NRAS_61L,61L,NA
single,Sex,NRAS,pancreatic cancer,Female,0,1153,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,pancreatic cancer,Male,0,1340,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,leukemia,Female,2,637,0.004,0.004,0.001,0.008,NRAS_61L,61L,NA
single,Sex,NRAS,leukemia,Male,4,930,0.004,0.004,0.001,0.008,NRAS_61L,61L,NA
single,Sex,NRAS,melanoma,Female,24,1104,0.024,0.024,0.015,0.034,NRAS_61L,61L,NA
single,Sex,NRAS,melanoma,Male,64,1742,0.035,0.035,0.027,0.045,NRAS_61L,61L,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,uterine cancer,Female,6,2253,0.003,0.003,0.001,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,0,724,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.004,NRAS_61L,61L,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.004,NRAS_61L,61L,NA
single,Sex,NRAS,ovarian cancer,Female,1,2336,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,esophagogastric cancer,Male,1,1297,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,thyroid cancer,Female,0,537,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,thyroid cancer,Male,0,480,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,cervical cancer,Female,0,365,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,hepatobiliary cancer,Female,0,636,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,hepatobiliary cancer,Male,0,738,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,0,124,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,cns cancer,Female,1,1994,0.001,0.001,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,cns cancer,Male,4,2569,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,prostate cancer,Male,0,2436,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.004,NRAS_61L,61L,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,neuroendocrine tumors,Male,0,193,0,0,0,0.001,NRAS_61L,61L,NA
single,Sex,NRAS,bladder cancer,Female,0,393,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,bladder cancer,Male,0,1187,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,0,106,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,0,142,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,small bowel cancer,Female,0,78,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,small bowel cancer,Male,0,132,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.006,NRAS_61L,61L,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.006,NRAS_61L,61L,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.002,NRAS_61L,61L,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0,0,0,0.006,NRAS_61L,61L,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0,0,0,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0.002,0.001,0,0.009,NRAS_61L,61L,NA
single,Sex,NRAS,small cell lung cancer,Male,1,205,0.004,0.003,0,0.015,NRAS_61L,61L,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,mesothelioma,Male,0,352,0,0,0,0,NRAS_61L,61L,NA
single,Sex,NRAS,germ cell tumor,Female,1,175,0.004,0.003,0,0.018,NRAS_61L,61L,NA
single,Sex,NRAS,germ cell tumor,Male,0,711,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,nerve sheath tumor,Female,0,80,0,0,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,nerve sheath tumor,Male,0,74,0,0,0,0.003,NRAS_61L,61L,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.002,0,0,0.027,NRAS_61L,61L,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.025,NRAS_61L,61L,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.004,0,0,0.052,NRAS_61L,61L,NA
single,Sex,NRAS,b cell lymphoma,Female,0,395,0.001,0,0,0.004,NRAS_61L,61L,NA
single,Sex,NRAS,b cell lymphoma,Male,1,567,0.002,0.001,0,0.005,NRAS_61L,61L,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.002,0,0,0.028,NRAS_61L,61L,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.002,0,0,0.029,NRAS_61L,61L,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.001,0,0,0.009,NRAS_61L,61L,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.001,0,0,0.01,NRAS_61L,61L,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.011,NRAS_61L,61L,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.001,0,0,0.009,NRAS_61L,61L,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.001,0,0,0.009,NRAS_61L,61L,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.035,NRAS_61L,61L,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.069,NRAS_61L,61L,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.003,0,0,0.041,NRAS_61L,61L,NA
single,Sex,NRAS,appendiceal cancer,Female,2,174,0.015,0.013,0.004,0.032,NRAS_61R,61R,NA
single,Sex,NRAS,appendiceal cancer,Male,3,167,0.016,0.015,0.005,0.036,NRAS_61R,61R,NA
single,Sex,NRAS,colorectal cancer,Female,25,3026,0.008,0.007,0.005,0.011,NRAS_61R,61R,NA
single,Sex,NRAS,colorectal cancer,Male,21,3694,0.006,0.006,0.004,0.009,NRAS_61R,61R,NA
single,Sex,NRAS,cancer of unknown primary,Female,3,1000,0.004,0.004,0.001,0.008,NRAS_61R,61R,NA
single,Sex,NRAS,cancer of unknown primary,Male,5,988,0.005,0.004,0.002,0.009,NRAS_61R,61R,NA
single,Sex,NRAS,non-small cell lung cancer,Female,6,5722,0.001,0.001,0.001,0.002,NRAS_61R,61R,NA
single,Sex,NRAS,non-small cell lung cancer,Male,9,4406,0.002,0.002,0.001,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,breast cancer,Female,0,9283,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,breast cancer,Male,0,48,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,soft tissue sarcoma,Female,2,1413,0.002,0.002,0,0.004,NRAS_61R,61R,NA
single,Sex,NRAS,soft tissue sarcoma,Male,4,1360,0.003,0.002,0.001,0.005,NRAS_61R,61R,NA
single,Sex,NRAS,pancreatic cancer,Female,3,1153,0.003,0.003,0.001,0.006,NRAS_61R,61R,NA
single,Sex,NRAS,pancreatic cancer,Male,4,1340,0.003,0.003,0.001,0.006,NRAS_61R,61R,NA
single,Sex,NRAS,leukemia,Female,8,637,0.012,0.011,0.006,0.02,NRAS_61R,61R,NA
single,Sex,NRAS,leukemia,Male,9,930,0.011,0.01,0.006,0.017,NRAS_61R,61R,NA
single,Sex,NRAS,melanoma,Female,82,1104,0.078,0.078,0.063,0.094,NRAS_61R,61R,NA
single,Sex,NRAS,melanoma,Male,164,1742,0.092,0.092,0.079,0.106,NRAS_61R,61R,NA
single,Sex,NRAS,head and neck cancer,Female,0,564,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,head and neck cancer,Male,0,1179,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,uterine cancer,Female,9,2253,0.004,0.004,0.002,0.007,NRAS_61R,61R,NA
single,Sex,NRAS,non-melanoma skin cancers,Female,0,183,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,non-melanoma skin cancers,Male,0,330,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Female,0,483,0.001,0,0,0.004,NRAS_61R,61R,NA
single,Sex,NRAS,myelodysplastic/myeloproliferative syndromes,Male,2,724,0.002,0.002,0,0.007,NRAS_61R,61R,NA
single,Sex,NRAS,adrenocortical carcinoma,Female,0,80,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,adrenocortical carcinoma,Male,0,54,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,ovarian cancer,Female,25,2336,0.011,0.011,0.007,0.015,NRAS_61R,61R,NA
single,Sex,NRAS,esophagogastric cancer,Female,0,504,0.001,0.001,0,0.004,NRAS_61R,61R,NA
single,Sex,NRAS,esophagogastric cancer,Male,3,1297,0.002,0.002,0,0.005,NRAS_61R,61R,NA
single,Sex,NRAS,thyroid cancer,Female,48,537,0.092,0.091,0.071,0.113,NRAS_61R,61R,NA
single,Sex,NRAS,thyroid cancer,Male,47,480,0.096,0.095,0.075,0.12,NRAS_61R,61R,NA
single,Sex,NRAS,cervical cancer,Female,1,365,0.003,0.002,0,0.011,NRAS_61R,61R,NA
single,Sex,NRAS,hepatobiliary cancer,Female,5,636,0.007,0.007,0.003,0.014,NRAS_61R,61R,NA
single,Sex,NRAS,hepatobiliary cancer,Male,4,738,0.006,0.006,0.002,0.012,NRAS_61R,61R,NA
single,Sex,NRAS,kidney cancer,Female,0,420,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,kidney cancer,Male,0,1002,0,0,0,0,NRAS_61R,61R,NA
single,Sex,NRAS,mature t and nk neoplasms,Female,0,107,0.003,0.001,0,0.016,NRAS_61R,61R,NA
single,Sex,NRAS,mature t and nk neoplasms,Male,1,124,0.007,0.005,0,0.025,NRAS_61R,61R,NA
single,Sex,NRAS,cns cancer,Female,3,1994,0.002,0.001,0.001,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,cns cancer,Male,4,2569,0.002,0.002,0.001,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,prostate cancer,Male,1,2436,0,0,0,0.002,NRAS_61R,61R,NA
single,Sex,NRAS,anal cancer,Female,0,102,0,0,0,0.002,NRAS_61R,61R,NA
single,Sex,NRAS,anal cancer,Male,0,47,0,0,0,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,neuroendocrine tumors,Female,0,166,0.002,0.001,0,0.011,NRAS_61R,61R,NA
single,Sex,NRAS,neuroendocrine tumors,Male,1,193,0.004,0.003,0,0.016,NRAS_61R,61R,NA
single,Sex,NRAS,bladder cancer,Female,2,393,0.004,0.003,0.001,0.011,NRAS_61R,61R,NA
single,Sex,NRAS,bladder cancer,Male,1,1187,0.002,0.001,0,0.004,NRAS_61R,61R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Female,1,106,0.01,0.008,0.001,0.028,NRAS_61R,61R,NA
single,Sex,NRAS,b-lymphoblastic leukemia/lymphoma,Male,1,142,0.009,0.007,0.001,0.025,NRAS_61R,61R,NA
single,Sex,NRAS,small bowel cancer,Female,1,78,0.012,0.009,0.001,0.037,NRAS_61R,61R,NA
single,Sex,NRAS,small bowel cancer,Male,1,132,0.01,0.008,0.001,0.029,NRAS_61R,61R,NA
single,Sex,NRAS,sex cord stromal tumor,Female,0,97,0,0,0,0.005,NRAS_61R,61R,NA
single,Sex,NRAS,sex cord stromal tumor,Male,0,10,0.001,0,0,0.01,NRAS_61R,61R,NA
single,Sex,NRAS,bone cancer,Female,0,242,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,bone cancer,Male,0,328,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,vaginal cancer,Female,0,78,0,0,0,0.006,NRAS_61R,61R,NA
single,Sex,NRAS,thymic tumor,Female,0,70,0,0,0,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,thymic tumor,Male,0,86,0,0,0,0.003,NRAS_61R,61R,NA
single,Sex,NRAS,ampullary cancer,Female,0,41,0.001,0,0,0.008,NRAS_61R,61R,NA
single,Sex,NRAS,ampullary cancer,Male,0,65,0.001,0,0,0.006,NRAS_61R,61R,NA
single,Sex,NRAS,small cell lung cancer,Female,0,193,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,small cell lung cancer,Male,0,205,0,0,0,0.001,NRAS_61R,61R,NA
single,Sex,NRAS,mesothelioma,Female,0,145,0.002,0.001,0,0.009,NRAS_61R,61R,NA
single,Sex,NRAS,mesothelioma,Male,1,352,0.003,0.002,0,0.01,NRAS_61R,61R,NA
single,Sex,NRAS,germ cell tumor,Female,0,175,0.002,0.002,0,0.009,NRAS_61R,61R,NA
single,Sex,NRAS,germ cell tumor,Male,3,711,0.004,0.004,0.001,0.009,NRAS_61R,61R,NA
single,Sex,NRAS,nerve sheath tumor,Female,1,80,0.014,0.012,0.001,0.042,NRAS_61R,61R,NA
single,Sex,NRAS,nerve sheath tumor,Male,1,74,0.015,0.012,0.001,0.042,NRAS_61R,61R,NA
single,Sex,NRAS,penile cancer,Male,0,25,0.002,0,0,0.019,NRAS_61R,61R,NA
single,Sex,NRAS,pheochromocytoma,Male,0,17,0.002,0,0,0.024,NRAS_61R,61R,NA
single,Sex,NRAS,pineal tumor,Male,0,12,0.003,0,0,0.029,NRAS_61R,61R,NA
single,Sex,NRAS,b cell lymphoma,Female,2,395,0.006,0.006,0.002,0.013,NRAS_61R,61R,NA
single,Sex,NRAS,b cell lymphoma,Male,4,567,0.007,0.006,0.002,0.014,NRAS_61R,61R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Female,0,12,0.003,0,0,0.037,NRAS_61R,61R,NA
single,Sex,NRAS,non-hodgkin lymphoma,Male,0,11,0.003,0,0,0.038,NRAS_61R,61R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Female,0,12,0.002,0,0,0.018,NRAS_61R,61R,NA
single,Sex,NRAS,t-lymphoblastic leukemia/lymphoma,Male,0,28,0.001,0,0,0.014,NRAS_61R,61R,NA
single,Sex,NRAS,retinoblastoma,Female,0,23,0.002,0,0,0.019,NRAS_61R,61R,NA
single,Sex,NRAS,retinoblastoma,Male,0,28,0.001,0,0,0.017,NRAS_61R,61R,NA
single,Sex,NRAS,hodgkin lymphoma,Female,0,16,0.002,0,0,0.026,NRAS_61R,61R,NA
single,Sex,NRAS,hodgkin lymphoma,Male,0,24,0.002,0,0,0.023,NRAS_61R,61R,NA
single,Sex,NRAS,lung cancer,Male,0,16,0.003,0,0,0.038,NRAS_61R,61R,NA
single,Sex,NRAS,blastic plasmacytoid dendritic cell neoplasm,Male,0,11,0.006,0,0,0.067,NRAS_61R,61R,NA
single,Sex,NRAS,peritoneal cancer,Female,0,17,0.002,0,0,0.026,NRAS_61R,61R,NA
